accepted abstracts apasl2016-alphabetical order 20160113 1/18apasl.info/apasl2016/doc/abstract...

Accepted Abstracts APASL2016-alphabetical order 20160113 1/18

Submission No. Last Name First Name Title of Abstract10989 Abbas Zaigham Co-Treatment with Pegylated Interferon Alfa 2a and Entecavir for Hepatitis D: A Randomized Trial10132 Abdalla Alaa Eldin Ibrahim 36 Weeks of Sofosbuvir-Ribavirin Combination Therapy for Egyptians with HCV Genotype 410071 Abdel motelleb Medhat A. Comorbidity of Diabetes Mellitus and Bleeding Esophageal Varices -Short Term Outcome10072 Abdel motelleb Medhat A. Combined Norfloxacin and Rifaximine as Primary Prophylaxis for Spontaneous Bacterial Peritonitis10005 Abdelatti Ehab A. Prevalence and Risk Factors of Hepatocellular Carcinoma in Egyptian Cirrhotic Patients10006 Abdelatti Ehab A. HBV: Challenges to Cure in the Future10643 Abdelatti Ehab A. HCC Burden in Egypt20020 Abd-Elsalam Sherief M. Is Spontaneous Bacterial Peritonitis Still Responding to Third Generation Cephalosporins? 20021 Abd-Elsalam Sherief M. Aflatoxin Role in Liver Cancer in Nile Delta20029 Abd-Elsalam Sherief M. Non Invasive Diagnosis of Esophageal Varices: Can It Replace Screening Endoscopy?10046 Abdulghany Ahmed Esophageal Varices and Platelet Sequestration, Effect of Variceal Eradication on Platelet Count10527 Abe Kazumichi Relationship between Serum Cytokeratin-18 (M30) and Primary Biliary Cirrhosis Pathology10299 Abe Masanori Characterization of Liver Myeloid-Derived Suppressor Cells in Nonalcoholic Fatty Liver Disease10292 Abe Tamami Noninvasive Assessment of Liver Fibrosis Using Shear Wave Elastography in Patients with CLD10624 Abe Tomoyuki Prognostic Significance of Modified Glasgow Prognostic Score in Patients with Gallbladder Carcinoma10050 Abedin Mohammad Forhad Chronic Liver Disease is One of the Leading Causes of Death in Bangladesh10855 Abei Masato Long Term Outcome of Proton Beam Therapy for Treatment-Naive Patients with Hepatocellular Carcinoma10280 Adnan Muhammad To Determine the Frequency of Upper GI Bleeding and Its Predicting Factors in CLD10282 Adnan Muhammad To Determine the Prevalence of Hepatitis B Disease Stages 10004 Adraneda Celina H. Predictive Upper Gastrointestinal Bleeding Score for Triaging Patients-Multicenter Validation Study10922 Adraneda Celina H. AFP as Predictor of Survival Rather Than Diagnosic Marker in Patients W/ HCC (Retrospective Cohort)10927 Adraneda Celina H. The FHCC-Pro:Prognostic Stratification Index of Filipino Patients with HCC- A Validation Study11099 Afdhal Nezam LDV/SOF 12 wks in A Real-Life Population of GT 1a and 1b HCV Patients; Data from the TRIO Network 10145 Afrin Mst. Rejina Curcumin Effectively Inhibits CXCL10 Associated Pathogenesis in the Liver of NASH-HCC Mice Model 11069 Agcaoili Jennielyn C. Prognostic Indicators of Mortality among Cirrhotics Admitted at the Intensive Care Unit11071 Agcaoili Jennielyn C. Left Ventricular Dysfunction Among Cirrhotic with Beta Blocker Therapy11073 Agcaoili Jennielyn C. RFA is Comparable to RFA and TACE among Patients with Intermediate Stage Hepatocellular Carcinoma10133 Aghayeva Gulnara Problems in Treatment of Cirrhotic HCV Patients in Azerbaijan- Retrospective Analyze20054 Aguilar Julio C. HeberNasvac: Rationalities and Preclinical Development of A Novel Hepatitis B Therapeutic Vaccine20053 Aguilar Julio C.. HeberNasvac: Clinical Development of A Therapeutic Vaccine10491 Ahishali Emel How Aware are Chronic Hepatitis B and C Patients of Their Diseases?10411 Ahn Sang Bong Fermented Soymilk Prevent Free Fatty Acid-Induced Lipogenesis in Hepatocellular Steatosis Model20082 Aizaki Hideki PREB and Surfeit 4 are Involved in HCV Replication Compartment by Interacting with NS4B10683 Akamatsu Nobuhisa Daclatasvir and Asunaprevir for Recurrent Hepatitis C Following Living Donor Liver Transplantation10745 Akarsu Mesut Reliability and Validity of UCLA SCTC GIT 2.0 for Turkish Population11030 Akazawa Yuko Elevated 53-Binding Protein 1 Nuclear Foci Expression in the NASH Liver 20138 Akbar Femmy Nurul Correlation between Lipid and BMI with Liver Fibrosis in NAFLD Patients 20096 Akbar Sheikh Mohammad Fazle A Novel Therapy for Chronic Hepatitis B; Proof of Concept, Mechanism, Clinical Trial & Registration10606 Akhan Sila Succesful Treatment with Daclatasvir/Asunaprevir of A HCV Patient after Failure of PEGIFN and RBV11213 Akhtar Tasleem Tacrolimus Induced Acute Hepatotoxicity in Wistar Rats10806 Akiyama Kentaro p62:Nrf2 Double Knockout Mice Develop Steatohepatitis through the Serum Endotoxin Overload10590 Akizue Naoki A Case of Metachronous Spontaneous Regression of Hepatocellular Carcinoma11059 Akkiz Hikmet Association between HBV Infection and HLA Gene rs3077 and rs9277535 in the Turkish Population10136 Aksoz Selcuk The Efficacy of Tenofovir in Patients with Chronic Hepatitis B20026 Aktug Demir Nazlim Assessment of Levels of Depression, Anxiety and Quality of Life in Chronic Hepatitis B Patients 20108 Akutagawa Maiko Cost-Effectiveness of IFN + RBVα2b for Hepatitis C: Results Based on the Interferon Database10335 Akyuz Filiz Clinical Yield of Radioembolization in Hepatocellular Carcinoma?11102 Aladag Murat Eight Years of PEG INF and Entecavir Therapy on HBsAg Loss and Seroconversion with Chronic HBV10049 Alam Md. Ashraful Pattern of Hepato-Pancreatic Diseases in Cox's Bazar Medical College Hospital10105 Alam Md. Ashraful Correlation of Hepatic Cirrhosis with Severity of Bone Changes Measured by BMD10756 Alam Shahinul Changes of Alanine Aminotransferase and Gamma Glutamyl Transpeptidase with Histology of Fatty Liver 20030 Ali Hussein Abd Elrazek Novel Sonar Techniques for Patients Awaiting Liver Transplantation Clinical and Cost Impacts10068 Altintas Engin Serum Chitotriosidase Levels in Malignant Diseases of Liver: Is It A New Tumor Marker?11100 Alves Eurico C. Impact of the Universal Drug Coverage Program to Eradicate the Burden of Hepatitis C in Portugal10096 Aly Hussein H. SKIV2L/RNA Exosome Mediated Regulation of Hepatitis B Virus11075 Amarapurkar Deepak N. Acoustic Radiation Force Impulse Elastography (ARFI) in the Diagnosis of Hepatic Fibrosis10007 Amin Amr Saffron-Based Crocin Prevents Liver Cancer: in Vivo, in Vitro and in Silico Insights11194 Anand Lovkesh Marrow Cellularity &Amp; Liver Disease Severity Predicts Regenerative Response to Therapy in Cirrhotics10944 Andrade Patricia A Prospective Evaluation of A Combination of Sofosbuvir/Ledipasvir Performance in HCV Infection10569 Andriani Febi Identification of Inter-Genotype Recombinant in Indonesian Chronic HCV Patient10575 Andriani Febi Primary Hepatocyte of Tupaia Javanica as A Model for Hepatitis C Virus Infection11007 Anzai Kazuya Identification of Mechanism Regulating Characters of Stem/Progenitor Cells during Liver Development10446 Aoki Taku Survival Outcomes of Cytoreductive Surgery for Advanced Hepatocellular Carcinoma10998 Aoki Tomoko Which is Useful for Liver Carcinogenesis Prediction Needle Biopsy or Liver Stiffness Measurement?10607 Aono Satoshi Successful Immunological Responses against Hepatitis B Virus in Immunologically Humanized Mice10640 Aoyama Tomonori The Prognosis of Patients with Liver Cirrhosis and Refractory Ascites Treated by Tolvaptan10206 Aoyama Toru Inhibitory Effects of Telaprevir on Orexigenic Ghrelin Secretion in Patients with HCV Infection10812 Arai Jun Decreased ISGs in B Cells of CH-C during IFN Free Therapy Suggest Eradication of HCV from B Cells10841 Arai Taeang Serum 25(OH)D3 Levels are Related to the Severity of Liver Fibrosis in Patients with NAFLD10906 Arano Toru Denver Peritoneovenous Shunt Selectively Enriches Life of Cirrhotic Patients with Refractory Ascites10940 Ari Alpay The Results of Long Term Lamivudine Therapy in Anti-HBe Positive Chronic Hepatitis B Patients10970 Arizumi Toshihiko Present Status of Primary Sclerosing Cholangitis in Japan -A Nationwide Survey-10560 Arshad Madeeha Adverse Effects of Sodium Arsenate Exposure to Gestational Mothers11267 Asano Takeharu Heart Failure and Liver Cirrhosis in Patients with Ascites10779 Asaoka Yoshinari The Improved Prognosis of Hepatocellular Carcinoma with Extrahepatic Spread Treated by Sorafenib20100 Ashimkhanova Aiymkul The Development of Organ Transplant Program in Kazakhstan10078 Ashraf Mohammad Shahed Alteration of Serum Lipid Profile with Severity of Liver Damage in Cirrhotic Patients10300 Aso Rika Tolvaptan Reduces Refractory Ascites in Patients with Advanced Liver Cirrhosis.10194 Asselah Tarik Efficacy of A Shortened 12-Week SMV+PR Regimen in HCV GT1 Patients According to IL28B Genotype

10908 Atanasov P. Real-World Effectiveness and Cost/SVR: Ledipasvir/Sofosbuvir(LDV/SOF) for Chronic HCV(CHC) Treatment

10909 Atanasov P. Real-World Effectiveness-8 Weeks(8w) Ledipasvir/Sofosbuvir(LDV/SOF) for Chronic HCV(CHC) Treatment

10087 Ates Fehmi The Importance of MTHFR A1298C and C677T Gene Polymorphisms in Non-Obese NASH Patients10205 Atmodjo Wahyuni Lukita Prevalence of Hepatitis-C Virus Infection within Community Health Centers in Tangerang, Indonesia10870 Au Nicholas T. Chinese Ethnicity does not Result in Clinically Relevant Differences in Sofosbuvir Pharmacokinetics11128 Au Nicholas T. No Clinically Relevant Differences in Sofosbuvir and Ledipasvir Exposure across Various Ethnicities10156 Aydin Ferzan Dose Serum Urotensin-II Have Role on Pathogenesis at Compensated and Decompensated Liver Cirrhosis?

Submission No. Last Name First Name Title of Abstract10599 Aydin Gule Prevalence of Hepatitis B Virus Serologic Markers in Pregnant Patients in A State Hospital in Turkey10600 Aydin Gule How does Maternal Hepatitis B Surface Antigen Carrier Status Impact the Preterm Delivery? 10796 Aydin Hayriye Seda The Evaluation of the Factors Affecting Seroconversions in HBeAg+ Chronic Hepatitis B Patients 11135 Aydogdu Ozcan Prevalence of Anti-HDV in Patients with Chronic Hepatitis B in Bafra County, Samsun Province, Turkey10081 Aygen Bilgehan Telaprevir Combination Therapy in Patients Infected with Hepatitis C Virus Genotype 410138 Ayyildiz Talat The Expression of Adipor1/R2 in Gastric Intestinal Metaplasia and Gastric Carcinoma10139 Ayyildiz Talat Coexistence of Gastrointestinal Stromal Tumor of the Stomach and Small Bowel Adenocarcinoma10164 Azam Mohammad Golam Serum Carbohydrate Antigen 19-9 (CA 19-9) in the Diagnosis of Malignant Obstructive Jaundice10632 Azam Mohammad golam Minimal Hepatic Encephalopathy among Patients with Cirrhosis of Liver: What is the Burden?10190 Baba Hayato A Case of Liver Dysfunction without An Elevation of ALT Caused by A Treatment of DCV and ASV10923 Baba Hayato Insulin Treatment Can Accelerate the Recurrence of Hepatocellular Carcinoma after Surgery10357 Baba Masaru Influence on Hepatitis C Virus Eradication on Hepatocellular Carcinogenesis10008 Badr Mohamed H. Urinary-NGAL as A Predictor of Acute Kidney Injury in Post-Liver Transplant Recipients11021 Bae Si Hyun Prepartum Use of Telbivudine on Preventing Mother–to–Child Transmission of Hepatitis B Virus

10981 Bae Sung Kwan The Risk Factors for Reactivation of Hepatitis B Virus after Hematopoietic Stem Cell Transplantation10399 Baik Soon Koo Effect of Decorin Expressing Adenovirus Infectied Mesenchymal Stem Cells on Cirrhosis Rat Model20048 Bair Ming-Jong Spontaneous Splenic Infarction in A Cirrhotic Patient20070 Bair Ming-Jong Eosinophilic Enterocolitis in A Patient with Chronic Hepatitis C10037 Baloch Mohsin Ali Zinc and Copper Concentration in Children with Chronic Liver Disease10036 Baloch Saira Hematological Changes and Occurrence of Anemia in Chronic Liver Disease11186 Ban Linda Extracellular Vesicles: Exploring A Novel Biomarker in Nonalcoholic Fatty Liver Disease Pathogenesis11048 Barbaras Ronald P2Y13 Receptor Agonist CER-209 Decreases Both Atherosclerosis and Liver Steatosis in Vivo11062 Barbaras Ronald P2Y13 Receptor Agonist CER-209, An Anti-Atherosclerotic Compound, Decreases Liver Steatosis in Vivo10025 Basaranoglu Metin There An Increase in the Prevalence of Hepatitis C Virus Subtype 3a in Turkey10028 Basaranoglu Metin Nonalcoholic Fatty Liver Disease Needs More Metabolic Abnormalities Than Polycystic Ovary Syndrome10290 Basaranoglu Metin Non-Alcoholic Fatty Liver Disease and PCOS10532 Basir Dewi Norwani Extra-Renal Malignant Rhabdoid Tumour in An Adult: A Rare Case of A Liver Tumor11242 Basir Dewi_Norwani Herpes Simplex Virus Hepatitis: Identification of Institutional Cases.10285 Basu P. Patrick Sofosbuvir and Ledipasvir Versus Sofosbuvir and Simeprevir for Acute Hepatitis C: A RCT: SLAM C Study10286 Basu P. Patrick Sofosbuvir and Ledipasvir for SVR12 in Sickle Cell Disease with HCV.SLASH C Trial10287 Basu P. Patrick Sofosbuvir, Ledipasvir in IBD Patients with Biologics Including Ribavirin for HCV: SOLATAIRE C Trial11240 Batirel Ayse Hepatitis B Virus in Pregnancy: Antiviral Treatment Efficacy and Risk of Perinatal Transmission10890 Baudi Ian Co-Infection of Hepatitis B Virus with HIV and Viral Characteristics in Zimbabwe10918 Baykam Nurcan Efficacy and Safety of Tenofovir in Patients with Chronic Hepatitis B: Four Year Real-Life Data10601 Baysal Birol Helicobacter Pylori in Pancreatic Adenocarcinoma10030 Bazeed Shamardan E. Serum Survivin and TIMP-1 as Non-Invasive Markers of HCV Induced Liver Fibrosis10031 Bazeed Shamardan E. ERCP Role in Management of Biliary Strictures in Southern Egypt20088 Beig Junaid Recurrent Hepatitis C after Liver Transplantation is Associated with Post-Transplant Diabetes10949 Bekhbold Dashtseren New-Estimation of Prevalence of HCV Infection in Mongolia 20064 Bekki Shigemune Serum Potassium Concentration is Associated with the Initial Effect of Tolvaptan to Liver Cirrhosis10534 Bekki Yuki WFA(+) -M2BP Interacts with Kupffer Cells Which Activates Hepatic Stellate Cells20067 Beppu Toru Portal Vein Embolization Followed by Right-Side Hemihepatectomy for Hepatocellular Carcinoma10506 Berg Thomas No Detectable TDF Resistance When Given Alone or With FTC in CHB Patients with LAM-R: 5 Year Results

10234 Bharali Dipu Expression Analysis of Plasma Apolipoprotein AI and AIV in Hepatocellular Carcinoma20032 Bhat Purnima HBV May Have An Enterohepatic Circulation: Implications for Viral Persistence and Tolerence10896 Bhate Prasad_ Ashok Cross Sectional Study of Prevalence and Risk Factors of Hepatitis B and C Infection in Rural India10674 Boctor Kerstina Further Exploration of the Effect of Body Positioning on Spleen Stiffness in Cirrhotic Patients.10689 Boctor Kerstina Retrospective Analysis of CHB Patients Referred to An Ontario Based FibroScan® Referral Program.

10707 Boctor Kerstina Spleen Stiffness: the Missing Link in Detection of Clinically Significant Portal Hypertension

10722 Boctor Kerstina Spleen Stiffness Alone vs. Liver to Spleen Stiffness in the Prediction of Portal Hypertension 

10746 Boctor Kerstina Retrospective Analysis of An Ontario Based Diagnostic Referral Program Using Transient Elastography.

11117 Boctor Kerstina The Correlation of RDW to Liver and Spleen Stiffness in Patients with Chronic Liver Disease

10695 Bodur Hurrem Peg-Interferon and Ribavirin in Naive Patients with Mild to Moderate Genotype1b Chronic Hepatitis C 10494 Boga Salih Serum Immunoglobulin A Level is A Predictor for Fibrosis in Non-Alcoholic Fatty Liver Disease10862 Boga Salih Hepatobiliary Cystadenoma Which Misdiagnosed as Hydatid Cyst: A Case Report10074 Bolukbas Fusun Relationship between Vitamin B12 Levels and Hepatic Fibrosis Detected with Fibroscan in NAFLD11297 Borkakoti Dr. Jayanta Is HEV Screening Necessary in Patients of Cirrhosis of Liver?10931 Borle Deeplaxmi P. HBIG Free Regimen for Preventing Post Transplant Hepatitis B Recurrence10751 Bosunia Zia H. To Evaluate Non-Invasive Predictors in Diagnosis of Nonalcoholic Steatohepatitis10911 Briand Francois Obese Insulin Resistant Diet-Induced NASH (DIN) Mouse as A Model for Evaluating Drugs Targeting NASH10913 Briand Francois Cyclodextrin Promotes Liver Inflammation and Fibrosis in High Fat/Cholesterol/Cholate Diet Fed Mice10067 Bruck Rafael Sortilin Deficiency Affects Fibrosis Differently in Hepatocyte vs. Cholangiocyte Models of Injury 10716 Bruck Rafael Improved HCV Disease Awareness and Screening Compliance Following A Public Media Campaign in Israel11095 Bruix Jordi Prognostic Factors and Predictors of Sorafenib Response in Patients with Hepatocellular Carcinoma10700 Budhiraja Sanchit ACLF: Clinical Profile and Factors Affecting Outcome11118 Budzinska Magdalena A. Genomic Landscape of Precancerous Liver Disease11330 Butt Amna S. Spectrum of Liver Disease during Pregnancy: A Cross Sectional Study from Pakistan10744 Butt Nazish Clinical Characteristics and Management Status of Hepatitis B: A Cross-Sectional Study11358 Butt Nazish Histoacryl&Reg Therapy of Bleeding Gastric Varices;the Experience of Tertiary Care Hospitals10288 Cai Yuli Adenosine 2A Receptor Deficiency Exacerbates NAFLD in Both HFD-fed and MCD-fed Mice 10511 Calica Utku Aylin Comparison of Entecavir and Tenofovir Effectiveness in Treatment-Naive Chronic Hepatitis B Patients10022 Camlibel Huriye Serum Visfatin, HBA1C, Insulin, C Peptide and Glucose Levels in Patients with Liver Cirrhosis11086 Cao Zhujun Acute on Chronic Liver Failure Induced by Hepatic Injury is Characterized by Massive Cell Death11266 Casadei Gardini Andrea Meld Score Predicts Outcome of Patients with HCC Treated with Sorafenib11268 Casadei Gardini Andrea SII Index Predicts Outcome in HCC Patients Treated with Sorafenib20130 Castro Benjamin Jr T. Clinical Implications of Muscle Wasting in Cirrhosis20094 Cavallone Daniela MiR-B-Index: A Biomarker to Identify the Immune Control of HBV Infection in CHB pts Treated with NA11082 Cerasari Giuseppe Sarcoidosis with Liver Expression10979 Cha Jung Hoon WT1 is the Key Regulatory of Hepatic Differentiation from Bone Marrow Mesenchymal Stem Cells20059 Cham Katrina Jewel S. Undiluted N-Butyl-2-Cyanoacrylate for Obliteration of Gastric Varices: A Single Center Experience20014 Cham Katrina Jewel S. Initial Experience with A Biodegradable Stent on the Management of A Benign Bile Duct Stricture20024 Cham Katrina Jewel S. Wire-Guide Saving ERCP Rendezvous Technique10831 Chan Anthony W.H. Integration of Albumin-Bilirubin (ALBI) Score into CLIP Staging for Hepatocellular Carcinoma10739 Chan Henry Lik Yuen Sofosbuvir/Velpatasvir (SOF/VEL) for 12 Weeks in Genotype 1, 2, 4, 5, 6 HCV Patients: ASTRAL-1 Study10942 Chan Henry_L.Y. Flares in Patients Treated with Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon (PEG)20085 Chan Wah Kheong A Randomized, Double-Blind, Placebo-Controlled Trial of Silymarin for the Treatment of NASH

Submission No. Last Name First Name Title of Abstract10864 Chang Chen-Wang Evaluate the Effects of Bacillus Coagulans in Functional Bowel Disorders10576 Chang Chia-Lin The Association between Quantitative Hepatitis B Core Antibody Level and HBV Seromarkers10426 Chang Joo H. Current Treatment Cost of Chronic Hepatitis B in China, Compared to Cost Based on Standard Guideline10758 Chang Kuo-Chin the Effect of Peginterferon 2a and 2b in Chronic HCV Patients under Response-Guided Therapy10743 Chang Pik Eu Optimal Liver Stiffness Values for Diagnosis of Liver Fibrosis and Cirrhosis 10768 Chang Pik Eu Portosystemic Gradient is Signifcantly Different on Day 5 Compared to Immediately Post-TIPS 20118 Chang Young Efficacy of Antiviral Treatment for Immune Tolerant Phase of Chronic Hepatitis B Patients 11173 Chanthra Nawin Association of STAT3 and STAT4 Polymorphisms and Hepatocellular Carcinoma10737 Charlton Michael Sofosbuvir/Velpatasvir for the Treatment of HCV Decompensated Liver Disease Patients: ASTRAL-4 Study10525 Chaudhri Eirum Elbasvir and Grazoprevir & Plusmn; Ribavirin for 8 or 12 Weeks in HCV GT1b-Infected Patients11097 Chayama Kazuaki UNITY-3: DCV/ASV/BCV in Treatment-Naive and IFN-Experienced Japanese Patients with HCV GT1 Infection

10673 Chayama Kazuaki GIFT-I: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir in Elderly Japanese Patients10585 Cheah Chang Chuen Liver Stiffness Measurement <12kPa Excludes Large Varices in Patients with Early Cirrhosis10536 Chen Chian-Feng Identification of Novel Liver Cancer Fusion Genes Using Chromosome Breakpoints Screening 10496 Chen Chien-Hung HBV Relapse and HBsAg Loss after LAM and ETV Therapy in HBeAg-Negative Patients with HBsAg≤200 IU/mL

10504 Chen Chien-Jen Disease Burden of Chronic Hepatitis C Virus (HCV) Infection in Taiwan 10554 Chen Chi-Ling Plasma Adiponectin Levels and Chronic HBV Infection Characteristics and Milestones20089 Chen Ching Hsiang The Excellent Outcome of Interferon-Based Hepatitis C Treatment in Taiwanese Incarcerated Patients 10088 Chen En-Qiang Serum apoA-V in Survival Prediction of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure10973 Chen Gaofeng Correlational Studies of Fibrotouch, Fibroscan and Ishak Score in Patients with Chronic Hepatitis B11207 Chen Guofeng Cost-Effectiveness of Response-Guided Therapy with Triple DAAs in Non-Cirrhotic CHC GT1b11245 Chen Guofeng Switching PEG-RBV to DAAs for Chinese with Chronic Hepatitis C GT1b10354 Chen Hsing Yu Impact of Occult Hepatitis B on the Clinical Outcomes of Patients with Chronic Hepatitis C Infection10400 Chen Jhen-Jyun Antioxidative Activity of Deferasirox (DFX) in Iron-Induced Oxidative Stress of Hepatocytes10059 Chen Jiamei Enhancement of Hepatocyte Differentiation from Human Embryonic Stem Cells by Chinese Medicine FZHY11231 Chen Jing Cost-Effectiveness of DAAs for CHC in Affluent Countries of Asia-Pacific Region 10971 Chen Liang-Chun Serum Levels of Mac-2 Binding Protein and the Associated Risk for HCC among CHC Patients11372 Chen Li-Wei The Association between NAFLD Fibrosis Score, FIB4 Index and Serum Vitamin D10675 Chen Ming-Jen Comparison of Telbivudine and Entecavir on Maintenance of eGFR in off-Treatment after 3-Years 10693 Chen Tao Restoration of CD56bright NK Cells Correlates with Antiviral Treatment Efficacy in CHB Patients20131 Chen Vincent L. Lower Survival with Cirrhosis in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)20132 Chen Vincent L. Survival Unchanged in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) from 2000-201511244 Chen Xiangmei NFATc3 Exerts Anti-Viral and Anti-Tumor Dual Function by Activating Interferon Pathway11305 Chen Yi-Cheng Patients with Active HBV had Worse Clinical Features Than Active HCV Alone in Dual HBV/HCV Infection10884 Chen Yong-Peng Stepwise Combining FibroScan and Routine Markers Improve Detecting Compensated CHB Cirrhosis11142 Chen Yi Mei Swee Lin G. Boceprevir is Active for the Treatment of Genotype 6 HCV20047 Cheng Chun-Han Gastric Polypoid Lesions in Cirrhotic Patients10810 Cheng Jenny YK. Metabolic Syndrome Increases CV Event but not Hepatic Event and Death in Chronic Hepatitis B10975 Cheng Jun HCBP6 Mediates the Reciprocation between Intracellular Total Cholesterol and Cell Autophagy11152 Cheng Robert Differential Gene Expression of miRNA in Plasma MV of Patients with Hepatocellular Carcinoma10441 Cheung Tan To Intraoperative ICG Measurement during Major Hepatectomy for HCC. Hype or Hope?10688 Cheung Ka Shing Relationship between HCC and Serum Markers in NA-Treated Patients with Undetectable HBV DNA 11226 Chi Xiao L A Noninvasive Assessment Model Based on Fibroscan is Good at Predicting Liver Fibrosis Progression 11237 Chi Xiao L. Baseline HBeAg and CH50 Predicts Early HBeAg Seroconversion in Chronic Hepatits B Patients10363 Chi Xiaoling Evaluating eGFR Changes in Chronic Hepatitis B Patients with Adefovir Add-on Therapy10124 Chien Cheng-Hung The Association between Hepatitis B/C Infection and Metabolic Syndrome in Northern Taiwan10322 Cho Hyo Jung Genetic Polymorphisms in the Wnt Pathway as Prognostic Predictors in HBV-Associated HCC11264 Cho Hyun Chin Clinical Significance of Circulating Endothelial Progenitor Cells in Patients with Liver Cirrhosis10112 Cho Jaiyoung Remnant Liver Ischemia is Associated with Early Recurrence and Poorer Survival after Hepatectomy10113 Cho Jaiyoung Validation of A Complexity Classification to Define Surgical Difficulty in Patients with HCC10250 Cho Sungbum Clinical Characteristics of Chronic Hepatitis C in the Elderly Patients20075 Cho Yuri Comparison between Liver Transplantation and Sorafenib for BCLC B or C Hepatocellular Carcinoma20076 Cho Yuri Activation of YAP-1 by c-Myc is A Therapeutic Target in Hepatocellular Carcinoma under Hypoxia10885 Choi Dae Hee Clinical Factors Correlated to Alcohol Withdrawal in Patients with Alcoholic Liver Disease20011 Choi Jong Sub Novel Mutations in the CPT1A Gene Identified of Carnitine Palmitoyltransferase 1A Deficiency10259 Choi Sungkyu Regional Differences of HCV and Clinical Characteristics of Chronic Hepatitis C in Jeollanam-Do 11228 Choi Wang Yong Change of Liver Cirrhotic Patients during 15 Years : Retrospective Multi-Center Study in Korea10207 Chon Young E. Serial Assessment of Fibrosis Regression Using Fibroscan in CHB Patients Receiving Antiviral Therapy10296 Chong Chern Hao Taking Charge of My Life: Advance Care Planning in Patient with End Stage Liver Disease10457 Chong Lee-Won Saturated Fatty Acid Induces Cancer Stem Cell-Like Properties in Human Hepatoma Cells10038 Chou Yi-Chun Risk and Mortality of Gastrointestinal Hemorrhage in Patients with Immune Thrombocytopenia10091 Chou Yi-Chun Adverse Outcomes after Non-Hepatic Surgery in Patients with Liver Cirrhosis: A Nationwide Study10095 Chou Yi-Chun Higher Mortality during Intensive Care Unit and Associated Factors in Patients with Liver Cirrhosis11205 Choudhary Manish_Chandra Progression of Liver Fibrosis in HCV Genotype 3a is Associated with Modulation in Let-7 miRNA Family11234 Choudhury Ashok K. AARC-ACLF Score Predicts 30 Day Survival Better Than CLIF-SOFA and MELD Scores in Patients with ACLF

11199 Chounta Athina A Cost of Illness Analysis of HCC in the Setting of Severe Financial Constraints 10516 Chowdhury Debnandan Dengue Hepatological Manifestation:from Acute Hepatitis to Fulminant Hepatic Failure11154 Chu Po-Sung NKG2D, the Mediator of Host T Cell Response, Correlates to Naturally Occurring HCV NS5A Variants11070 Chu Yu-Ju Elevated Aflatoxin B1-Albumin Adducts Increase Cirrhosis and Cirrhotic Hepatocellular Carcinoma Risk

11083 Chu Lee Han Regional Differences in Transarterial Chemoembolization (TACE) Use in HCC: Optimis Interim Analysis10834 Chuang Wan-Long A Phase 2 Dose Finding Study for P1101 + Ribavirin in Patients with Chronic HCV Genotype 1 Infection10245 Chuang Wan-Long A Phase 2 Dose Finding Study for P1101 + Ribavirin in Patients with Chronic HCV Genotype 2 Infection10336 Chuaypen Natthaya HBsAg and cccDNA Reduction in HBeAg-Positive and HBeAg-Negative CHB Treated with Peginterferon11166 Chuaypen Natthaya Quantification of cccDNA and pgRNA in Patients with HBeAg-Negative CHB Treated with Peg-IFN11211 Chuaypen Natthaya HBsAg and cccDNA Reduction in Patients with CHB Receiving PEG-IFN with or without Entecavir11227 Chuaypen Natthaya Kinetics of Serum HBcrAg during PEG-IFN Therapy in Patients with HBeAg-Negative CHB10648 Chuma Makoto Molecular Pathogenesis for HCC Development: HSF1 Potential Molecular Target for HCC Therapies10564 Chung HyunJung N-Terminal Pro B-Type Natriuretic Peptide is Useful Diagnostic Markers for the New Onset Ascites. 10610 Chuon Channarena Prevalence of HCV and HBV, and Characteristics of HCV Genomes among General Population in Cambodia10715 Chutaputti Anuchit Effect of Addition AHCC on HBsAg Level in Patients with CHBeAg Negative on Long Term OAA Treatment

11274 Co Vanessa O. Endoscopic Ligation and Beta Blocker Versus Monotherapy in Primary Prophylaxis of Variceal Bleeding 11110 Cong Min Exosomal microRNA Panels as Biomarkers Predicting for Progress of HBV-Induced Liver Cirrhosis10093 Cox I. Jane Urinary Proton NMR Spectroscopy in A Bangladeshi Cohort as A Fingerprint for HCC10125 Dai Chia-Yen Association between microRNA Let-7g and Hepatitis C11326 Danalioglu Ahmet May Triple Therapy Still be An Alternative to Standard Therapy in Patients with Chronic Hepatitis C?10274 Dang Khue Kim Liver Transplantation in Adults in Viet Duc University Hospital: A Single-Center Experience

Submission No. Last Name First Name Title of Abstract10786 Danilau Dzmitry Comparative Study of Efficacy of Lamivudine and Tenofovir in Treatment for Chronic Hepatitis B11222 Dar Sadaf B. Circulating mir-150 and mir-342 as Potential Biomarkers to Predict HCC Progression in HBV Patients10570 Date Yusaku A Case of Small Hepatocellular Carcinoma with Bile Duct Tumor Thrombus 10306 Deguchi Akihiro Usefulness of Angio CT for the Diagnosis and Treatment of Early Hepatocellular Carcinoma11029 Delgersaikhan Zulkhuu Alarming High Prevalence of HDV Infection in Mongolia10714 Demir Mehmet Fragmented QRS and Decompensated Cirrhosis10465 Demirci Hakan Is Serum Uric Acid Risk Factor for Non-Alcoholic Fatty Liver Disease?10173 Demirturk Nese Cases of Chronic Hepatitis C Treatment in Hemodialysis Patients11361 deng guangying Role of TLR8 Mediated Antiviral Immunity in Chronic Hepatitis B10500 Deng Hong Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter and A New Algorithm11339 Deng Yong-Qiong Angiopoietin-Like Protein 2, A Novel Biomarker for Liver Histology in Chronic Hepatitis B Patients20079 Deng Yong-Qiong Effect of ALT on Transient Elastography Diagnosing Liver Fibrosis in Chronic Hepatitis B Patients10121 Derbala Moutaz 12 W of Sofosbuvir/Simeprevir in Genotypes 1 and 4 in HCV, Cirrhotic Patients : Qatar Experience10129 Derbala Moutaz F. Aspartate Transaminase to Platelet Ratio Index (APRI) in HCV and Schistosomiasis Coinfection11353 Dertli Ramazan Transfusion Related Acute Lung Injury (TRALI) Due to Iatrogenic Intra-Abdominal Bleeding20046 Devaliya Divyesh Community Interventions and Sensitisation on Hepatitis B Infection with Pregnant Women & Babies 10934 DeVecchis Wygant Gail EQ-5D Results in Asian Patients with HCV G1b Receiving DCV+ASV Who are IFN Intolerant/Ineligible10721 Devrajani Bikha Ram Vitamin D Levels in Cirrhosis and Chronic Liver Disease11316 Dharod Mrudul V. Determining Modes of Transmisson of Hepatitis C Virus (HCV)10663 Ding HuiGuo Comparison of Different Screening Schemes for Patients with Hepatitis B Associated Cirrhosis10664 Ding HuiGuo Effects of Liver Steatosis on the Progression and the Antiviral Response in Chronic Hepatitis B10665 Ding HuiGuo PI3K/Akt/mTOR Signaling Pathway Mediates Hepatoma Cell Autophagy Induced by Hydrogen Sulfide20027 Dittharot Kanthanadon Metabolomic Profiling of Human Urine from Hepatitis B Virus Infected Patients Using GC/MS10717 Dogan Tolga Successful Treatment with Steroid of Autoimmune Hepatitis in A Patient with Rectum Adenocarcinoma10638 Doganay Levent HLA DPB1*15:01 Predicts Spontaneous HBsAg Seroconversion in Chronic Hepatitis B10775 Dohi Chihiro A Strategy to Diagnose Hepatocellular Carcinoma by EOB-MRI10952 Doi Yoko Two Cases of Hepatocellular Carcinoma with Autoimmune Hepatitis10907 Donchuk Dmytro Hepatitis C Treatment in A Primary Care Clinic in the High HCV Burden Setting in Karachi, Pakistan11026 Dong Yi Efficacy and Safety of INF Combined with LAM in Treatment of Cirrhotic Children with Hepatitis B10472 Du Lingyao Hepatitis C Virus Might Regulate Suppressor of Cytokine Signaling-1 Gene Methylation to Tumorgenesis10029 Duh Pin-Der The Protective Effect of Djulis and Its Bioactive Compounds against CCl4-Induced Liver Injury11281 Duman Deniz Guney Effects of the Mesenchymal Stem Cells on Common Bile Duct Ligated Rats 11292 Duman Deniz Guney Nonalcoholic Fatty Liver Disease is Associated with Erectile Dysfunction: A Prospective Pilot Study 10202 Dybowska Dorota Resistance Analysis of Unsuccessfully Treated with Telaprevir Genotype 1 HCV Infected Patients 10317 Ekinci Omer Factors Associated with A Higher Alfa-Fetoprotein Level in Patients with Hepatocellular Carcinoma10408 Ekstrom Victoria A Novel Blood-Based 3-Gene Signature to Predict Development of Early Human Hepatocellular Carcinoma10177 Elateek Mohamed Interfamilial Transmission of Hepatitis C Genotype 4 in Egypt11008 El-Azab Gasser Serum Apelin as A Non-Invasive Marker for Nonalcoholic Steatohepatitis10826 Elfert Asem Study of Hepatic Steatosis Index in Patients with Chronic HCV Infection10661 Elfert Asem A. Is Microwave Ablation A Good Alternative to Partial Splenic Embolization to Treat Hypersplenism?20025 Elghamry Fathy Egy-Score Can Predict Portal Hypertension in Chronic Hepatitis C with Good Accuracy20146 Elghamry Fathy T Cell Subpopulation Predict the Occurrence and Prognosis of Cryoglobulinemia in Chronic Hepatitis C10182 El-Kassas Mohamed Serum Fibrosis Biomarkers Can Predict Presence of Hepatocellular Carcinoma in Chronic Hepatitis C20022 Ellithy Rania_Mohamed SNPs Analysis of Oligo-Adenylate Synthatase & Interleukin 1B Genes in End-Stage Liver Disease10815 Elnoemany Karim S. Combination of Lactulose, Rifaximin and LOLA in Treatment of Minimal Hepatic Encephalopathy10694 Elsiesy Hussien A. Rabies Outbreak Involving Four Transplant Recipients in Kuwait and Saudi Arabia 10401 Endo Mizuki Noninvasive Assessment of Liver Fibrosis Using RTE and A Novel Serum Marker:WFA+-M2BP

10085 Enomoto Masaru Sequential Therapy with Short-Term Entecavir Followed by Interferon in Chronic Hepatitis B Patients10436 Erdem Aytac Follow-up of the Chronic HBV Infected Patients Planned Chemotheraphy Due to Solid Organ Malignancy11214 Faiyaz Rahiman C3a Receptor Blockade Reduces Liver Regeneration Post-Hepatectomy in LPS-Hyporesponsive C3h/HeJ Mice

10023 Fan Hsiang-Hsuan In Vivo Study on the Roles of HBx and HCP in Pathogenesis by Conditional Mouse Models20153 Fan Yu-Chen Elevated A20 Gene Expression in PBMCs is Associated with Acute-on-Chronic Hepatitis B Liver Failure10867 Fang Long Effect of Type-2 Diabetes Mellitus on Platelet Count in Hepatocellular Carcinoma10384 Farghaly Ahlam M. Serum Extracellular Matrix Degradation Inhibitors across Stages of Liver Fibrosis in Chronic HCV 20111 Farooqi Javed I. RESiP Study: Real-Life Experience with Sofosbuvir in Pakistan20122 Farooqi Javed I. Viral Kinetics in HCV Genotype 3 Patients Treated with Sofosbuvir in Pakistan. Data from RESiP Study20124 Farooqi Javed I. Efficacy and Safety of Sofosbuvir in HCV-Related Advanced Liver Cirrhosis. Data from RESiP Study20125 Farooqi Javed I. Correlation of Virological & Clinical Profile of Patients with BC-Coinfection in Pakistan20126 Farooqi Javed I. Transient Elastography by FibroScan for the Assessment of Liver Fibrosis: First Study from Pakistan20128 Farooqi Javed I. IL28B Polymorphism as in Chronic Hepatitis C Genotype 3 20133 Farooqi Javed I. Pretreatment Determinants of Early Virologic Response in Sofosbuvir Treated Patients.20139 Farooqi Javed I. Rifaximin in the Treatment of Early Hepatic Encephalopathy 20140 Farooqi Javed I. Characteristics of HCV-Related HCC in Pakistan 20141 Farooqi Javed I. Complications Profile of Liver Cirrhosis in Pakistan11017 Farrukh Syed Zea-ul-Islam Body Mass Index in Hepatitis B & C Related Liver Disease;First Fibroscan Based Study from Pakistan.20069 Feng I. Che Perihepatic Nodes by Point-of-Care Ultrasound in Acute Hepatitis and Acute-on-Chronic Liver Disease10262 Feng Ren The Dysregulation of ER Stress Response in AoCLF Patients Caused by Acute Exacerbation of CHB10103 Fingas Christian D. Expression of PRK/PLK3 is Associated with A Less Invasive Tumor Biology in Cholangiocarcinoma10102 Foez Syed Abul Ascitic Fluid Cholesterol May be A Good Parameter to Asses the Severity of Liver Cirrhosis11335 Fu Junliang BTLA Up-Regulation Impaired CD8+ T-Cell Function and Accelerated Disease Progression of HCC Patients11250 Fujisaka Yasuyuki The Developing the Detection Method of Immune-Mediated Drug-Induced Liver Injury 10076 Fujisawa Koichi Adenylate Kinase 4 Modulates Drug Sensitivity and Mitochondrial Activity10333 Fujiwara Naoto Functional Age is A Stronger Predictor of the Outcomes of HCC Than Chronological Age11243 Fujiwarwa Naoto Fibroscan is More Predictive of Hepatocarcinogenesis in Chronic Hepatitis C Than Serum Markers10444 Fukui Aiko Factors Related to Skeletal Muscle Volume in Patients with Chronic Hepatitis C10670 Fumitaka Suzuki GIFT-I: Durability of Response of Ombitasvir/Paritaprevir/Ritonavir in HCV GT1b Japanese Patients11307 Fung Scott 5 Year Efficacy and Safety of Tenofovir DF in Lamivudine-Resistant Chronic Hepatitis B Patients11054 Furusyo Norihiro Simeprevir- and Telaprevir-Based Therapies for Non-Responders with Genotype 1b Chronic Hepatitis C11045 Furutani Kengo Aortic Aneurysm and Aortic Dissection in Patients with Autoimmune Hepatitis: A Report Od Four Cases10849 Futsukaichi Yuka The Significance of Immune Cells in Peripheral Blood with Hepatocellular Carcinoma11094 Gabr Mamdouh Aflatoxion B1 as A Preventable Risk Factor in the Development of HCC in Egyptian Patients11189 Gan Aaron TM. An Unusual Hepatic Tumour in an Patient with Chronic Hepatitis B10735 Gane Edward LDV/SOF+RBV in HCV Patients with Decompensated Cirrhosis or Liver Transplantation: SOLAR-1+210941 Gane Edward J. Ledipasvir/Sofosbuvir for 12 Weeks is Safe and Effective for Patients with HBV and HCV Coinfection10985 Gani Rino A. Role of VEGF as A Predictor of Survival in HCC Patients Receiving Supportive Treatment10591 Gao Chun Effect of Type-2 Diabetes Mellitus on Blood Pressure in Hepatocellular Carcinoma

Submission No. Last Name First Name Title of Abstract10183 Gao Qiang Deep-Sequencing Reveals Clonal Evolution and Genomic Heterogeneity in Multifocal Liver Cancer11364 Gao Yuhua An Early Decrease of HBeAg in CHB Patients Strongly Predicted Treatment Response during NAs Therapy10741 Garimella Tushar Evaluation of Daclatasvir and Asunaprevir Exposures in Non-Japanese Asians, Japanese, and Caucasians10427 Gelli Veena Shravanthi HBV Reduces IRF3 Gene Expression Despite Increased Expression of Cellular Cytosolic DNA Sensor cGAS10150 Ghazinyan Hasmik Acute Hepatitis C (AHC)11167 Ghazinyan Hasmik Liver Injury Due to Epstein Barr Virus (EBV)10123 Gherlan George S. Fibroscan–are10 Valid Measurements Mandatory?10748 Gherlan George S. The Agreement of Transient Elastography (TE) and Acoustic Radiation Force Impulse Imaging (ARFI)10094 Gill Muzzaffar Outcomes of SOF and RIBA Therapy for HEP C G3 Patients Who are Relapsers of Peg INF and RIBA10174 Gill Muzzaffar Outcomes of Sof, Riba & Peg-INF Therapy for Treatment of Chronic HEP-C G3 Treatment Naive Patients10685 Gill Muzzaffar Outcomes of Endoscopic Retrograde Cholangiopancreatography in Patients with Cirrhosis10692 Gill Muzzaffar L. Outcomes of Sofosbuvir and Ribavirin for the Treatment of HCV Recurrence after Liver Transplantation10615 Gish Robert High Rates of Surface Antigen Loss, Low Rates of Seroreversion in Asian Chronic HBV Patients20112 Gocho Takeshi Efficacy of Sorafenib in Patients with Intermediate-Stage HCC Refractory to TACE10921 Goenka Mahesh K. ARFI Elastography Correlation with Liver Biopsy in the Evaluation of Staging of Fibrosis.10901 Goh Brian K. Importance of Tumor Size as A Prognostic Factor after Liver Resection for Solitary HCC10903 Goto Eriko Efficacy and Safety of Daclatasvir and Asunaprevir in Elderly Patients with HCV Genotype1b Infection10397 Gou Wei Efficacy of LDT+ADV Combination Therapy and ETV Monotherapy for CHB Patients with High Viral Load10237 Guillen Gerardo E. Evidences of Antifibrotic Effect of the Growth Hormone Relasing Peptide 6 10696 Gulsen Murat T. The Association between Chronic Hepatitis b/c Infection and Metabolic Syndrome10873 Gunal Ozgur HBV-HIV Co-Infection, A Case Report10519 Gunsar Fulya Clinical Presentations of Autoimmune Hepatitis20092 Guo Guanya Severe Vitamin D Deficiency Identifies A Poor Pognosis in Patients with Primary Biliary Cirrhosis11336 Guo Jinsheng Identification of Axon Guidance Signaling Pathway in Hepatic Stellate Cells and Liver Fibrogenesis10596 Guo-Jian Wang Epidemiologic Features in Chinese Descent in Burmese with CHC in Hospital of Dehong District, China11303 Gupta Birendra Prasad Three Novel Amino Acid Substitutions in RNA Dependent RNA PolymeraseAccelerates HEV Infection10703 Gupta Raman K. Donor Derived Dengue Infection in Living Donor Livertransplantation Recepient: Case Report10175 Guven Emre Investigation of the Effect of PON1 and IL28B Gene Polymorphism on HCV Infection Progress 10179 Habba Eslam Correlation of Platelets Count with Endoscopic Findings in Egyptian Patients with Liver Cirrhosis10882 Haga Hiroaki Evaluation of Pretreatment RAVs Benefits for Improved Outcomes in Daclatasvir/Asunaprevir Therapy 11006 Haga Hiroaki The Efficacy of Danaparoid Sodium on Portal Thrombosis in Patients with Hepatic Cirrhosis11041 Haga Yuki Effect of IFN on TLR-Associated Gene Expression in Hepatoma Cells with Integrated HBV DNA10547 Hai Hoang NS5A RAVs in DAA-Naive HCV Genotype 1b Japanese Patients were Associated with Patients' Background10533 Hakim Suharno Acute Liver Failure Caused by Valproic Acid11329 Hakim Suharno Profile of Chronic Hepatitis C Treated with Interferon Based Regimen in Sardjito General Hospital10409 Hamada Yuki Laennec® Can Improve Type 2 Diabetes Complicating with NASH through Normalizing Iron Metabolism

10413 Hamada Yuki Human Placental Extract Can Replace the Phlebotomy on Treating Hereditary Hemochromatosis10657 Han Guorong Long-Term Safety of Infants Born to LDT Treated Pregnancy with CHB during 2nd or 3rd Trimester10539 Han Jinchao Artificial Peptides Derived Hepatitis C Virus Core Protein Interfere Virus Replication in Vitro10542 Han Meifang Altered Expression of STAT1, MX and SOCS3 Associated with Outcome of Therapy in HBV Infection20173 Han Mi Ah Associations between Vitamin D Level and Serum Aminotransferase Concentration in Korea 10584 Haq Muhammad_Mansoor UL Outcome of Patients Treated with N-Butyl-2-Cyanoacrylate in Gastric Variceal Bleeding10993 Haqqi Syed Afzal-ul-haq Fibroscan:A Novel Modality; Initial Results from Low Cost Tertiary Care Centres of Pakistan11225 Haqqi Syed Afzal-ul-haq Pegylated Interferon in HCV Genotype 3 Relapsers to Conventional Interferon in Pakistani Population 10558 Haque Mohammad Sayedul Sero-Prevalence of Acute Hepatitis Caused by HAV and HEV in Gazipur, Bangladesh10946 Hara Yuichi Iron Chelator Suppresses Hepatocarcinogenesis Through Mitophagy Induction in STAM® Mice11355 Haraguchi Masafumi Geranylgeranylacetone Exerts Anti-Hepatitis B Virus Activity by Suppressing Enhancer-1 Activity11257 Harrison Stephen A. Novel Quantitative Assessment of Liver Fibrosis in NAFLD10597 Hassanein Tarek High SVR Rates with ABT-493 + ABT-530 in Non-Cirrhotic Patients with HCV Genotypes 1, 2, 3 Infection10018 Hatanaka Takeshi Prediction of Response to Tansarterial Chemotherapy with CDDP Powder for Hepatocellular Carcinoma10019 Hatanaka Takeshi Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Located in the Caudate Lobe10119 Hatanaka Takeshi Gastric Varices Successfully Treated by Shunt Occlusion-Endoscopic Injection Therapy: A Case Report10709 Hatanaka Takeshi Factors Relevant to Incomplete Ablation at First Session of RFA in 403 HCC Patients10578 Hayashi Eiichi DC-Based Immunotherapy with T Cell Immunoglobulin and Mucin Protein 3 Blockade in A Murine HCC Model

10734 Hayashi Kazuhiko The Antiviral Therapy Based on HCV NS5A Resistant Mutations in Hepatitis C Virus Genotype 1b.10883 Hayashi Manabu Frequency of Surgical Site Infection after RFA without Maximal Sterile Barrier Precautions10792 Hayashi Sanae Novel Nucleoside Analogs Exert Antiviral Replication against HBV with Drug Resistance Mutations20060 He Gai X. A Novel Regulatory Mechanism of Hepatic Myeloid-Derived Suppressor Cell Accumulation10435 Heo Jeong HBsAg Decline after Pegylated-Interferon-Alpha in HBeAg Positive with Nucleoside Maintenance11010 Herceg Zdenko Epigenome Deregulation in Liver Carcinoma11027 Hidaka Hisashi Long-Term Outcomes of B-RTO for Prevention of First or Second Bleeding of Gastric Fundal Varices10507 Hige Shuhei Resistance-Associated Variants in Hepatitis C Patients Who Failed Direct Acting Antiviral Treatment10224 Hikita Hayato Chronic Apoptotic Stimuli in Hepatocytes Induces Oxidative Stress Leading to Development of HCC10669 Himoto Chikara Efficiency of Sorafenib in Japanese Patients with Hepatocellular Carcinoma: A Multicenter Experience10406 Himoto Takashi Contribution of Copper to HIF-1Α Activation in the Process of Hepatocarcinogenesis 10304 Hiraishi Tetsuya Adverse Effects of Combined Administration of Daclatasvir and Asunaprevir10372 Hiramatsu Akira Measurement of Muscle Mass Using CT is Useful to Diagnose Sarcopenia in Patients with Cirrhosis10228 Hiramatsu Katsushi Identification of SNPs in HLA Class II Gene Related to Disease Progression of Chronic Hepatitis C11015 Hiramine Satoshi Length of TA Repeat Near IL28B was Associated with HCV Spontaneous Clearance in Egyptian Population10431 Hiraoka Atsushi Interventional Radiology for Hepatocellular Carcinoma in Patients with Child-Pugh C10456 Hirooka Masashi Usefulness of A Three-Dimensional Simulator System for Multipolar Ablation20147 Hirotsu Yosuke Targeted and Exome Sequencing Analysis of Hepatocellular Carcinoma20148 Hirotsu Yosuke Somatic Mutations in Non-Tumorous Fibrotic Tissue20039 Hlaing Tin Tin Persistent Spontaneous Bacterial Peritonitis in the Patient with End-Stage Liver Disease10512 Ho Erwin China on the Scheldt:HBV and HCV in the Chinese Population in Belgium and Study of Screening Methods10118 Ho Harvey Modelling of Hepatic Flow Variations Due to Liver Resection and Transplantation10850 Ho Hsin-Ling Homocysteine Deteriorates Intrahepatic Derangement and Portal-Systemic Collaterals in Cirrhotic Rats10313 Hododuka Masanori Minimal Hepatic Encephalopathy Diagnosed with Neurophysiological Test in Cirrhotic Patients10211 Honda Koichi Efficacy of Daclatasvir plus Asunaprevir for Hepatitis C in Patients Non-Positive for NS5A Variants10995 Hong Young Mi The Prescription Pattern of Acetaminophen and NSAIDs in Patients with Liver Cirrhosis10785 Honma Yuichi Sorafenib Enhances Cytotoxicity Via Inhibition of Cellular Defense Mechanisms10057 Hossain Sharker Mohammad Shahadat Comparison between TDF vs ETV in Patients with Hepatitis B Related ACLF in Bangladesh10010 Hotta Naoki Usefulness of 4D Us to Evaluate Effects Therapeutic RFA for HCC10365 Hou Jinlin 192 Weeks Tenofovir Disoproxil Fumarate Monotherapy in Chinese Patients with Chronic Hepatitis B20101 Hou Wei Pyrosequencing Analysis of HBV S Gene "a" Determinant Mutation in HBsAg+/Anti-HBs+ Patients

20127 Hou Wei Subcellular Localization of Cyclin G1 During Mitosis in JFH1-hmAG Infected Huh7.5 Cells

Submission No. Last Name First Name Title of Abstract10429 Hou Wei Wei Cost-Effectiveness Analysis of Sofosbuvir for Treatment-Naive G1 Chronic Hepatitis C in China10440 Hsieh Meng-Hsuan The HDV Infections among Injecting Drug Users with and without HIV Infection in Taiwan10443 Hsieh Meng-Hsuan Boceprevir-Based Triple Therapy to Rescue HCV Genotype 1/HBV Dually Infected in Taiwan10639 Hsieh Sen-Yung Functional Genomics Identified A Novel EMT-MET Regulator for Human Hepatoma Invasion11047 Hsieh Yi-Chung Predictors of Refractory Chemoembolization in Patients with Hepatocellular Carcinoma 11255 Hsu Chao Wei Telbivudine Treatment in Chronic Hepatitis B Patients: A Prospective, Real World Experienced Study10769 Hsu Ching-Sheng Impact of Antiviral Therapy on Hepatitis C Patients After Curative Hepatocellular Carcinoma Therapy10730 Hsu Hui Ting The Diagnostic Accuracy for Early Stage Hepatocellular Carcinoma by Combined Use of AFP and PIVKA-II10954 Hsu Shao-Jung The Beneficial Effects of Curcumin in Cirrhotic Rats with Portal Hypertension20023 Hu Ai rong NUCs Improves the Long-Term Prognosis in Patients with CHB-Associated Liver Failure20044 Hu Airong Analysis of HBV Gene Mutations Related to NAs in Chronic HBV Infection11223 Hu Anne B. Failure to Detect: Late Hepatocellular Carcinoma (HCC) Recurrence after Liver Transplantation (LT)11294 Hu Chi-Tan Screening of c-Met-Positive Hepatocellular Carcinoma for c-Met-Based Target Therapy10577 Hu Hui-Han HBV Infection, Persistence, Immunity, and HLA and NTCP SNPs: An Analysis of Taiwan Biobank Data10926 Hu Peng The Pharmacoeconomics Value for HBeAg-Positive CHB Patients to Switch from NUCs to PEG-IFN-α-2a

10556 Hu Xiao PPAR&Alpha Can Attenuate Dietary Trans-Fatty Acid-Induced Liver Changes11134 Hu Yue Acute Liver Failure Caused by Mushroom Poisoning A Case Report11296 Hua Rui HCV Genotype-Specific Epitope Peptides Screen and B-Cell Epitope Prediction 11302 Huang Chien-Hao the Prognosis of Patients with Acute on Chronic Liver Failure Who were Admitted to ICU10003 Huang Chung-Feng PNPLA3 Genetic Variants Determine HCV-Related Hepatic Steatosis in Asian Non-Obese Patients 10794 Huang Chun-i Role of IL-28B Genetic Variants in HCV Related Liver Disease Severity11053 Huang Daniel Human Amniotic Epithelial Cell Exosomes Reduce Proliferation of Hepatocellular Carcinoma Cell Lines11051 Huang Jee-Fu the Role of 25-Hydroxy Vitamin D in Hepatitis C Virus Replication and Treatment Viral Kinetics11193 Huang Kai-Wen Endostatin Gene Delivery after Irreversible Electroporation for Hepatocellular Carcinoma10064 Huang Mingxing Tenofovir Added on Other Nucleoside-Analogues was not Superior to TDF Monotherapy 10154 Huang Mingxing Comparison of the Effectiveness of Tenofovir in Nucleoside Analogue Naive and Experienced in CHB10698 Huang Mingxing Artificial Liver Support System with Recombinant Human Growth Hormone in Chronic Liver Failure 10116 Huang Peng Genetic Variants in Interferon-Lambda 4 Influences HCV Clearance in Chinese Han Population10131 Huang Pengfei Sorafenib Resistance Can be Overcome by Mfn2 Through Inhibiting HIF-1Α Expression in HCC11158 Huang Rui B Cells May Play A Pathological Role in Hepatic Inflammation in Chronic Liver Diseases10339 Huang Shiu-Feng Introduction of Taiwan Liver Cancer Network10594 Hung Chao-Hung Combined Resection plus Radiofrequency Ablation Versus Transarterial Embolization for BCLC-B HCC20110 Hung Chao-Hung A Randomized Controlled Trial of Glycyrrhizin in Chronic Hepatitis B with Severe Acute Exacerbation10380 Huster Dominik Impact of Atp7b Deficiency on Hepatic Cholesterol Metabolism and Atherosclerosis in Atp7b-/-Mice

10263 Hyo Jung Cho Serum Interleukin-6 Levels as A Predictive Marker in Patients with Hepatocellular Carcinoma 10247 Hyun Jong J. Comparison on the Efficacy of Endoscopic Snare Papillectomy with or without Submucosal Injection20061 Ide Kazuki Regional Differences in Hepatitis C Treatment in Japan: A Study Using A Nationwide Database10432 Ide Tatsuya Predictive Markers of Viral Response to Daclatasvir/Asunaprevir in HCV Genotype 1 Patients10415 Ideta Takayasu NASH-Related Hepatocarcinogenesis is Suppressed in Mice Lacking Hepatic Retinoid Storage 10915 Igarashi Ataru Cost-Utility Analysis of Ledipasvir/Sofosbuvir for Treatment of GT 1 Chronic Hepatitis C in Japan 10917 Igarashi Ataru Cost-Utility Analysis of Sofosbuvir for the Treatment of Genotype 2 Chronic Hepatitis C in Japan 10308 Igarashi Go A Case of Severe Sclerosing Cholangitis Following Critical Ill with Extensive Burn Injury10897 Iimuro Yuji Role of Portal Flow Dynamics in the Hepatic Morphological Changes Associated with Liver Fibrosis10433 Iino Yotaro RT Combined with TACE in Advanced HCC Patient Having Hepatic Vein Invasion10791 Iio Etsuko Efficacy and Adverse Events of Daclatasvir/Asunaprevir in Chronic Hepatitis C Genotype1b11183 Ikeda Hiroki Impact of RAV Dominancy on Treatment Outcomes in HCV GT1B Patients for Daclatasvir and Asunaprevir10898 Ikeuchi Miho The Effect of Female Hormones on NAFLD in p62 Knockout Mice.10101 Imai Yasuharu Elasticity Modulus by Real-Time Color Mapping Shear Wave Elastography in SVR Patients of CH-C10254 Imamura Akihiro Whole Liver Chemoembolization with Cisplatin and Trisacryl Gelatin Microsphere for Multiple Hepatoma11089 Imamura Jun The Effectiveness of Danaparoid Sodium for Portal Vein Thrombosis11159 Imran Dr Muhammad Paired FIB-4 Score in Successfully Treated Chronic Hepatitis C with Pegylated Interferon & Ribavirin10687 Inagaki Chiaki PIIINP is A Useful Marker of Disease Activity in Hypereosinophilic Syndrome with Hepatic Involvement10360 Inoue Jun Alteration of Hepatitis B Virus Release after the Disruption of Clathrin-Dependent Endocytosis11060 Inoue Kazuaki Effective Early Interventions are Essential to Attain High Survival Rate10963 Inoue Masanori Risk Factor of Distant Recurrence of HCC Following RFA; Gd-EOB-DTPA-Enhanced MRI Based Analysis10176 Inoue Takako Application of Highly Sensitive CLEIA for HBsAg: An Appropriate Method to Detect Occult HBV Viremia10947 Isbambetov Askhat Systemic Administration of MSCs for Hepatic Ischemia Reperfusion Injury in A Rat Model10595 Ishikawa Hiroto A Case of Mucinou Carcinoma of the Liver10701 Ishikawa Toru Double Platinum Therapy TAI and TACE for BCLC B Hepatocellular Carcinoma10001 Islam Abu Saleh Mohammad Sadequl Diagnostic Utility of AFP in Hepatitis B Related Hepatocellular Carcinoma10002 Islam Abu Saleh Mohammad Sadequl Terminal Stage of Hepatitis B Related Hepatocellular Carcinoma is Unsuitable for Treatment10392 Itaba Noriko Human Mesenchymal Stems-Engineered Hepatic Cell Sheets Therapy for Acute Liver Injury10827 Itakura Jun Hepatitis C viruses with Y93H Mutation in NS5A Region are Susceptible to Interferon-Based Therapy20155 Itakura Jun Residual RAVs after Daclatasvir and Asunaprevir Combination Therapy -Multicenter Study in Japan10679 Ito Daisuke Recurrent Acute Hepatitis Induced by Organic Solvents10668 Ito Hiroyasu Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the Development of CCl4-Induced Liver Fibrosis10248 Ito Jun Prevalence and Characteristics of Naturally Occurring Sofosbuvir Resistance-Associated Variants10349 Ito Kiyoaki Mechanisms of Interaction between Host Glycosylation System and Hepatitis B Virus Replication System10887 Ito Sayaka Detection of Hepatitis C Virus NS5A L31/Y93 Mutations in Patients with Hepatitis C10858 Itokawa Norio Serum M2BPGi and HVPG are Useful Factors Predicting the Effect of Tolvaptan on Hepatic Edema20037 Ivashkin Vladimir A Novel Mutation of ATP8B1 Gene in Young Patient with Familial Intrahepatic Cholestasis10814 Iwasaki Yoshiaki A Common Variant in the PNPLA3 in University Students with Non-Alcoholic Fatty Liver Disease10479 Iwasawa Kentaro Dysbiosis of the Gut Microbiota in Primary Sclerosing Cholangitis (PSC) in Children10501 Izumi Kazuhiro Clinical Evaluation of Sorafenib Treatment and HAIC for Advanced HCC11101 Izzi Antonio Functional Cure of HBV in A Severe Immunocompromised Patient with CLL Treated with Entecavir10329 Jaafar Khairul A. Hepatitis B Surface Antigen (HBsAg) Levels and Hepatitis Be Antigen (HBeAg) Seroconversion Status11309 Jadoon Nauman A. Relationship of Chid-Pugh and Meld Scores with in-Hospital Mortality in Decompensated Cirrhosis11315 Jadoon Nauman A. Prevalence and Predictors of Thrombocytopenia in Advanced Liver Disease11322 Jadoon Nauman A. Presence of Anemia Predicts Advanced Grade at Presentation in Patients with Hepatic Encephalopathy10680 Jahan Munira Necessity of Anti-HBc and ALT Screening for Blood Donors in Bangladesh11259 Jain Priyanka Comparison of the Acute on Chronic Liver Failure Severity Score - A Need for Simple and Dynamic One20143 Jazag Amarsanaa Cause of Cirrhosis in Mongolia Evaluated by Non-Invasive Methods Including Fibroscan, FIB4 and APRI10894 Jeng Rachel Wen-Juei Elevation of ALT during Nuc Treatment Enhances HBsAg Decline11216 Jeng Rachel Wen-Juei Impact of IL28B Polymorphism on HCV Viremia in Dual HBV and HCV Infected Patients11288 Jeng Rachel Wen-Juei Clinical Relapse after Cessation of Tenofovir in HBeAg Negative Patients: Presentation and Predictor10728 Jeon JeongSuk Effect of Vitamin B6, Vitamin B12 and Folic Acid on Serum Homocysteine Level

Submission No. Last Name First Name Title of Abstract10146 Jeong Jae Yoon Both Elevation of HVPG and LS Can Predict Mortality in Non-Critically Ill Patients with Cirrhosis 10253 Jeong Sook-Hyang Direct Medical Cost for Hepatitis C Virus Infection in South Korea, 2009-201310939 Jeruma Agita 100 % Efficacy of Hepatitis C Treatment in Cirrhotic Patients: Real Life Results in Latvia11252 Ji Dong Pan-Oral Direct Acting Antiviral Agents for CHC GT1b Chinese-A Real Life Experience11341 Ji Fanpu Effect of Splenectomy on Immune Cell State in Hepatitis C Virus Related Cirrhotic Patients11343 Ji Fanpu Long-Term Clinical Outcome of HCV Decompensated Cirrhotic Patients after Antiviral Treatment10418 Jia Ji D. Effectiveness of NAs Therapy in Real World Naive Chinese CHB Patients: Results from Evolve Study10711 Jiang Xia Effects of Lin28B on Human Colorectal Carcinoma and HBV-Associated Hepatocellular Carcinoma10851 Jiao Baihai the Role of Ubiquitin Specific Protease USP18 in Interferon Resistance of HCV 11204 Jiao Guohui PD-1 as An "Immune-Check Disturbance" with Infiltrated CD8+CXCR3+ T Cells Modify PBC clinical Course

10645 Jin Guang-Zhi A Novel Prognosis Scoring System for Intrahepatic Cholangiocarcinoma11172 Jin Jinglan Aberrant Methylation of Inflammatory Pathways in HBV Infection10830 Jinato Thananya Analysis of Human microRNAs Profiles in Response to HBV Transfection and Peg-IFN Treatment by NGS 11208 Jindal Ankur Sofosbuvir and Ribavirin for Chronic Hepatitis C: Interim Analysis from A Real-Life Indian Cohort10561 Jing You The Research of Th17/Treg in Patient with HBV-Infected and Its Relationship with Liver Function10586 Joo Jong Seok Treatment Efficacy of Tenofovir in Treating Drug-Resistant Chronic Hepatitis B10378 Jose-Abrego Alexis High Prevalence of HBV Infection, Genotypes H, F1b and G in Socially Vulnerable Mexican Risk Groups 11272 Joshita Satoru Asymptomatic and Symptomatic States are Independent Risk Factors Predicting PBC Long-Term Outcome 10629 Jun Baek Gyu Lamivudine with Adefovir Dipivoxil Therapy does not Worsen Renal Function in Chronic Hepatitis B10261 Jun Chunghwan A Case of Hepatic Hemangioma with Kasabach-Merritt Syndrome in An Adult Patient 10451 Jung Kyu Sik Partial Virological Response with Entecavir is not Risk Factor of HCC Occurrence.10452 Jung Kyu Sik Long Term Entecavir Treatment Results in Viral Suppression and Fibrosis Regression 10184 Junrungsee Sunhawit Super Marginal Liver Graft; Lacerated Liver in Open Abdomen Setting; A Case Report10936 K. C. Sudhamshu Hepatic Vein Waveforms are Independent of Liver Fibrosis in Chronic Hepatitis C Patients10844 Kagawa Tatehiro Shortened 12-Week Simeprevir/Peginterferon/Ribavirin Therapy for GT 1b Chronic Hepatitis C Patients10355 Kai Yugo DAA Therapies for Treatment-Emergent Variants of HCV in Humanized Liver Chimeric Mice10636 Kaibori Masaki Effect of Introducing An ERAS for Patients Undergoing Resection of HCC10637 Kaibori Masaki Effect of Intramuscular Adipose Tissue Content on Prognosis in Patients Undergoing HCC Resection10635 Kaibori Masaki Intraoperative Detection of Superficial Liver Tumors by Fluorescence Imaging Using ICG and 5-ALA10373 Kaida Takayoshi Preoperative Platelet-to-Lymphocyte Ratio (PLR) Predicts Recurrence Status after Initial Hepatectomy10324 Kaido Toshimi Impact of Pretransplant Sarcopenia on Survival after Liver Transplantation: A Prospective Study 11246 Kaishima Terumi Cost-Effectiveness Analysis Related to HCV Treatment is Possible to be Estimated in Each Province10872 Kajihara Mikio Detection of Blood Microbiota and Dysbiosis in Patients with Liver Cirrhosis10222 Kakisaka Keisuke A Predictive Formula for the Prognosis of Patients with Acute-on Chronic Liver Failure11163 Kalkan Cagdas Sustained Virological Response in Dual Infection of Chronic Hepatitis B and C11185 Kalkan Cagdas Telbivudin Treatment Experience of A Single Center 10289 Kalwar Mansoor A. Endoscopic Findings around Gastroesophageal Junction. Experience from Tertiary Hospital in Pakistan11270 Kamani Lubna Gender Specific Etiological Spectrum of Ercp in Hepatopancreaticobilliary Diseases10216 Kamani Lubna Safety of Conscious Sedation in Patients Undergoing ERCP with HepatoBiliary Disease10417 Kamezaki Hidehiro A Case of PJP Diagnosed during Treatment with 15 mg Prednisolone Daily for AIH10266 Kamimura Kenya Development of Effective Gene Therapy for Liver Fibrosis 10430 Kan Toshiki Daclatasvir/Asunaprevir Treatment Reduces Liver Fibrosis11098 Kanda Tatsuo Invader Assay for HCV NS5A RAVs is Excellent for the Prediction of Outcome of DCV/ASV Treatment20162 Kanda Tatsuo Sofosbuvir-Including Regimens against Real-World Japanese Patients with HCV GT-1 and GT-220168 Kanda Tatsuo Effects of Androgen Receptor on Fatty Acid Metabolism in Human Hepatoma Cell Lines20169 Kanda Tatsuo GRP78 is An Antiviral Factor and One of the Antiviral Targets against Hepatitis A Virus Replication10377 Kandemir Ozlem Distribution of Hepatitis C Virus Genotypes in Injection Drug Users with Chronic Hepatitis C10453 Kanefuji Tsutomu Share Wave Velocity Fits the Risk Assessment of HCC Development Especially in NAFLD20003 Kaneko Shun A Model for Interaction between HBV and Host Cells Derived from Human Induced Pluripotent Stem Cells10366 Kaneto Miho A Case of Hepatitis Due to Hypereosinophilic Syndrome11036 Kang Byeong Ju Acute Kidney Injury after Liver Transplantation does not Affect the Patients' Mortality10776 Kang Dae Hwan Vorinostat-Incorporated Nanoparticles for Local Delivery into Human Cholangiocarcinoma Cells11174 Kang Jingting Down-Regulation of NTCP in Proliferating Hepatocytes by p53 and Cyclin D1 has Clinical Significance10135 Kang Jong-Hon Transition of Etiology in Acute Liver Failurein Hokkaido, Japan-Emerging New Cause11220 Kang Jui-Wen Comparison of the Effects of TACE with T-ACE Beads and Other Microspheres - A Porcine Study 10608 Kang Seong Hee Diagnostic Performance for Small Hepatocellular Carcinoma Measuring Less Than 2cm10609 Kang Seong Hee Long Term Follow up of Chronic Hepatitis B Patients after Oral Antiviral Treatment Discontinuation10189 Kanogawa Naoya SVR of Interferon-Based Therapy as A Prognostic Factor for HCV-Related Hepatocellular Carcinoma10765 Kanomata Hiroyuki A Case of Asymptomatic Mucinous Cystic Neoplasm of the Liver with Marked Calcification 11072 Kao Jia-Horng All-Oral Daclatasvir/Asunaprevir/Beclabuvir Fixed-Dose Combination Therapy for HCV Genotype 110098 Kao Wei-Yu Ten-Year Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma11263 Kar Premashis Detection of HBsAg, HBeAg and HBV DNA Load in Saliva of HBV Carriers20033 Karagoz Ergenekon ARFI is A Useful Tool in Patients with Chronic Hepatitis B Infection: A Case Report20034 Karagoz Ergenekon Correlation Between Quantitative HBsAg Levels and Clinical Profile of Chronic HBV Patients20035 Karagoz Ergenekon Utility of ARFI in the Follow-Up of A Patient with Chronic Hepatitis B: A Case Report10660 Karakan Tarkan Ecstasy Induced Steroid-Responsive Acute Hepatitis10438 Karasahin Omer Neopterin as A Marker for Immune Status in Patients with Chronic Hepatitis B11324 Karasu Zeki Long-Term HBV Prophylaxis with Oral Anti-Virals after HBIg Discontinuation10514 Karim Md. Fazal Needle Stick Injury: An Alarming Problem for Healthcare in Bangladesh10672 Karino Yoshiyasu GIFT-I: Ombitasvir/Paritaprevir/Ritonavir Safety and Efficacy in Renally-Impaired Japanese Patients10151 Katayama Hokahiro Generation of Transgene-Free Hepatocyte Like Cell with Transposon Mediated Direct Reprogramming10293 Katsumi Tomohiro Up-Regulated miR-139-5p in Hepatocytes Induce TNF&Alpha Similar to Clinical Sera from PBC Cases10268 Kawabe Naoto The Usefulness of Markers for Diagnosis of NAFLD Comparing with Chronic Hepatitis C10656 Kawaguchi Kazunori Notch Ligand DNA Copy Number Variation is Enhanced in HBV-Related Liver Cancer10069 Kawaguchi Takumi DPP4 Inhibitor Suppressed Tumor Progression and Nrf Expression in A Mouse Model of NASH-Related HCC

10332 Kawai Kengo Epidemiologic Study for Acute Hepatitisin Recent Years in Toyama Area10342 Kawai Toshihiro EVL Following Variceal Rupture in Patients with Hepatocellular Carcinoma and Portal Vein Thrombosis20002 Kawai-Kitahata Fukiko Comprehensive Analyses of Mutations and Hepatitis B Virus Integration in Hepatocellular Carcinoma10423 Kawakami Takamasa Prognostic Scoring System for Radiofrequency Ablation: Usefulness of ALBI-Grade10231 Kawamura Etsushi Danaparoid Sodium Thrombolytic Therapy Followed by Warfarin in Cirrhotic Portal Vein Thrombosis10987 Kawano Youichi Our Novel Way to Insert Sheet Type Materials at Laparoscopic Hepatectomy: Corkscrew Insertion Method10405 Kawaoka Tomokazu Comparison of HAIC and Sorafenib in HCC Patients Refractory to TACE 10541 Kawaratani Hideto Predictive Value of the Efficacy of Tolvaptan in Patients with Refractory Ascites in Liver Cirrhosis10809 Kawashima Keigo Host and Viral Determinants for Differential Hepatitis B Virus Clearance between Genotypes10058 Kaya Safak A Case with Hepatitis C Undergoing Kidney Transplantation after Telaprevir Containing Triple Therapy10160 Kaya Selcuk Liver Involvement in Leptospirosis Patients


Submission No. Last Name First Name Title of Abstract10090 Kayaaslan Bircan Entecavir Versus Tenofovir in Treatment of Nucleoside Analogue-Naive Chronic Hepatitis B Patients10996 Kazunari Tanaka Clinical Characteristics in Acute Presentation of Autoimmune Hepatitis20164 Khaneshi Mohammad Three Important Disorders Regarding Hepatitis C in the Middle East 10603 Khawar Muhammad Babar Hepatotoxicity of Industrial Leachate; Histopathology and Heavy Metal Contents in Liver10213 Kikuchi Masahiro Utility of Quantitative Controlled Attenuation Parameter to Diagnose Alcoholic Liver Disease10359 Kim Byung Seok Prolonged Tenofovir Monotherapy for Partial Virologic Response to Tenofovir in Chronic Hepatitis B10252 Kim Dae-Ghon MAP Promotes HCC and Metastasis Through the mTORC1 and Β-Catenin Signaling Pathways20043 Kim Daejin HAV IgG Seroprevalence among HBV Liver Disease in Daegu city of South Korea10616 Kim Do Young Elimination of Hepatitis C Virus (HCV) in South Korea11020 Kim Dong Joon Liver Cirrhosis and Cancer: Comparison of Mortality and Economic Burden10383 Kim Hong Soo Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma as A Local Salvage Treatment20090 Kim Hyon-suk Sensitivity of Elecsys HBsAg II Assay in Detection of HBsAg Mutant Forms in Korean HBV Patients10340 Kim Jeong Han Predictive Value of MELD, APRI, and FIB-4 for Mortality and Development of HCC in Cirrhotic Patients10341 Kim Jeong Han Clinical Features of Spontaneous Bacterial Peritonitis; Ten Years Single Center Experience10393 Kim Joo S. A Rare Infectious Complication after Living Donor Liver Transplantation10390 Kim Jung Hee The Risk of Preclinical Atherosclerosis in Non-Diabetic, Non-Hypertensive Adults by NAFLD10264 Kim Jung Hee Locoregional Therapy or Liver Transplantation for Hepatocellular Carcinoma Fulfilling Milan Criteria20129 Kim NamHee Clinical Significance of Focal Hepatic Solid Lesions Incidentally Detected on Ultrasonography10552 Kim Seok Hyun Atypical Onset of Bicalutamide-Induced Liver Injury10555 Kim Seok Hyun Two Cases of Spontaneous Intramuscular Hematoma Survived in Liver Cirrhosis Patients10543 Kim Shinhee Comparison of Obliteration of Gastric Varices and Technical Success between BRTO vs PARTO10778 Kim Su Jim Photosensitizer-Incorporated Chitosan Nanoparticles for Treatment of Cholangiocarcinoma11371 Kim Su Jin Effect of Time Interval for Prevention of Variceal Rebleeding in Patients without Active Bleeding10350 Kim Suk Bae The Necessity of Computed Tomography to Hepatic Lesions Detected on Private Clinic Sonography10540 Kim Sung Eun Mutations at rtS202, rtM250 May Cause Poor Viral Response to Tenofovir Rescue in Chronic Hepatitis B20045 Kim Sung Hoon The Meaning of AFP, AFP-L3 and PIVKA-II for Evaluating Recurrence in Patients with HCC10362 Kim Taesuk Assessment of Insufficient Viral Response during Entecavir Therapy in Treatment naïve CHB11081 Kim Yoona A. Low Liver Disease Screening and Treatment Rates in Mongolia: Results from a Physician Survey10321 Kim Young Nam FIB-4 Can Predict HCC Development in CHC Patients with SVR to Interferon-Based Combination Therapy10450 Kimura Koichi Exacerbation of Fatty Liver Ischemic Reperfusion Injury Through NADPH Oxidase Signal Transduction11126 Kimura Kouji The Clinicopathological Analysis of Collagen XV, Which Contributes Sinusoidal Capillarization11348 Kimura Kouji A Case of Postoperative Hepatic Encephalopathy after Total Cavopulmonary Connection Conversion10386 Kimura N Possible Involvement of Activating Follicular Helper T Cells in Autoimmune Hepatitis10275 Kimura Yushi HBV DNA Levels on HBE Seroconversion Could Predict Clinical Course in Chronic Hepatitis B 10991 Kinoshita Ayaka Rapid Progression of Hepatocellular Carcinoma in Neuropeptide Y Knockout Mice under High Fat Diet10265 Kinoshita Masahiko the Association between Non-Alcoholic Steatohepatitis and Intrahepatic Cholangiocarcinoma10649 Kirnake Vijendra Non Invasive APRI Score in Cirrhosis Correlates with Invasive Hepatic Venous Pressure Gradient?10144 Kishi Yoji Prognosis after Resection of Locally Recurrent HCCs Following Four Types of Local Treatment10073 Kishida Yutaka Chronic Hepatitis C with Restoration of Innate-Immunity with N-IFN-Beta Followed by Simeprevir 11000 Kita Sadahiko Transplantation of Hepatocyte Like Cells from Human Mesenchymal Stem Cells into F344-Scid Gamma Rat10334 Kitade Mitsuteru Augmentation of Hepatic Progenitor Cells-Mediated Liver Regeneration by Antifibrotic Therapy 10566 Kitahara Masaaki OK432-Stimulated Monocyte-Derived Dendritic Cell Injection into HCC after RFA10618 Kitano Yuki E-PASS Scoring System is A Good Predictor of Prognosis in HCC Patients Underwent Major Hepatectomy10158 Kiyono Soichiro Yearly Variation in the Portal Hemodynamic Parameters on Doppler Sonography20170 Kiyono Soichiro Utility of Sonazoid-Enhanced Ultrasonography for Diagnosis of Portal Hypertensive Gastropathy10220 Ko Frankie C.F. Study of DLC1 Regulates Oxidative Stress for Tumor Suppression10217 Koda Masahiko Predictive Factors for Local Tumor Progression after Radiofrequency Ablation for HCC10080 Kodama Kazuhisa Comparison of Complications between Nonalcoholic Fatty Liver Disease vs Alcoholic Liver Disease10375 Kodama Masanobu An Essential Role of Nuclear Receptors in Hepatic Lipid Metabolism in Hypertensive Rat with NASH10445 Koga Futa Bolus Administration of CDDP with 5FU in Hepatic Arterial Infusion Chemotherapy for Advanced HCC10526 Koga Hironori Regulation of Hes1 Expression by the Wnt Transcription Factor T-cell Factor-410084 Kogiso Tomomi An Efficacy and Safety of Daclatasvir/Asunaprevir Therapy for HCV-Positive Kidney Transplantation11170 Kogure Takayuki Involvement of Autophagy in Resistance to Sorafenib Induced by Hypoxia in Hepatocellular Carcinoma10291 Koizumi Yohei Usefulness of Elastography for Diagnosis of Liver Fibrosis and Disease Progression in PBC Patients10840 Koklu Seyfettin Daclatasvir plus Asunaprevir in Difficult to Treat HCV Gt1b Population, EAP Turkey Experience11333 Koksal Ali Riza Relationship between Adipocytokine Levels and Post-ERCP Pancreatitis Risk11328 Koksal Iftihar Results of Long-Term Monitoring of Treatment-Naive Genotype 1b Chronic Hepatitis C Patients 10106 Komatsu Haruki Lack of Infectivity of HBV in Feces from Patients with Chronic Hepatitis B Virus Infection11136 Kon Kazuyoshi Screening for Fatty Liver: Characteristics of Patients with Hepatic Steatosis without Elevated ALT 10676 Kondo Chisa Efficacy of Daclatasvir/Asunaprevir for Chronic Hepatitis C Patients with Renal Insufficiency10140 Kondo Masaaki Hepatic Arterial Infusion Chemotherapy with Cisplatin and Sorafenib in Hepatocellular Carcinoma10999 Kondo Mayuko The Characteristics of Hepatocellular Carcinoma with Elevated AFP-L3 Level and Normal AFP Level10269 Kondo Reiichiro Pathological Characteristics of Spleen in Liver Cirrhosis and Idiopathic Portal Hypertension10628 Kondo Yasuteru HBV-Inducing miRNAs Could Affect the Biological Process and the Expression of HBs-Antigen10367 Kondrackiene Jurate Diagnostic Value of Tests Commonly Used in the Diagnosis of Intrahepatic Cholestasis of Pregnancy11253 Kong Fei Increased Galectin-3 Expression is Related to Poor Prognosis in Hepatocellular Carcinoma20150 Kono Hiroshi M-CSF Receptor Antagonist Inhibits Progression of Hepatocellular Carcinoma in Vivo 10281 Korah Tarek Role of Serum Glypican-3 in the Diagnosis of Small Hepatocellular Carcinoma 10713 Korenaga Keiko Usefulness of the FibroScan® XL Probe in Patients with Nonalcoholic Fatty Liver Disease10538 Korenaga Masaaki Ledipasvir/Sofosbuvir Reduces Risk Factors Associated with HCC in Patients with Chronic Hepatitis C11093 Kose Sukran Evaluation of Serum qHBsAg Levels and Liver Biopsy in Inactive Hepatitis B Carriers10572 Kosone Takashi Direct Acting Antiviral Agents Can be Safely Used for Hepatitis C with Hepatocellular Carcinoma.11077 Kristo Anila Age and Gender Influences on Chronic Hepatitis C (CHC) Patients Treated with PegINF and Ribavirin11084 Kristo Anila Biochemical and Hematological Profile at Baseline Predicts Non-SVR in Chronic Hepatitis C Treatment10755 Kubo Atsushi A Case Report of Carcinosarcoma of the Lower Bile Duct with Polypoid Growth11092 Kudo Masatoshi Practice Patterns, Sorafenib Dosing and Safety in Asian Hepatocellular Carcinoma Patients in Gideon20080 Kugiyama Yuki Serum M2BPGi and Sodium Level are Associated with Increased Risk of Mortality in Patients with LC11366 Kulkarni Sandeep S. Nutritional Assessment in Cirrhosis of Liver10879 Kumagai Junichiro An Older Patient with Autoimmune Hepatitis, Which Drugs-Induced Liver Injury Probably May Trigger10314 Kumagi Teru Access to Healthcare did not Change the Clinical Features and Long-Term Outcomes of HCC in Japan 20102 Kumar Naveen Safety and Efficacy of Pyrazinamide in Compensated Cirrhosis: Time to Shun Hepatotoxicity Fear?10920 Kumar Rahul Comparison between NASH and ASH Induced Hepatocellular Carcinoma (HCC)10172 Kumar Rajneesh Similar Intrahepatic, Serum Virus-Load and HCC in Hepatitis B Genotype B&C with Advanced Fibrosis10997 Kumar Vinoth A Study on Distribution of HCV Genotypes in South India10236 Kuo Yuan-Hung Using Non-Invasive Apri, FIB4-Score and Liver Stiffness to Identify Cirrhosis in the Community10568 Kurniasih Tri S. HCV Quasispecies Complexity and Diversity of Indonesian Chronic HCV Patients Treated with PegIFN/RBV


Submission No. Last Name First Name Title of Abstract10803 Kurniawan Andree Clostridium DifficileIinfection in Liver Cirrhosis Patients Increased Risk of Malnutrition10545 Kuroda Hidekatsu Visualization of the Vascular Architecture Using SMI Reflects the Fibrosis in Patients with HCV10983 Kurokohchi Kazutaka Sequential Therapy (PEI-RFA at First-IVR at Second for Large Sized Hepatocelllular Carcinoma.10828 Kurosaki Masayuki HBs Antigen Reduction by Peg-Interferon Sequential Therapy after Long Term NUC10137 Kurt Omer The Relationship of Pentraxin 3 with Atherosclerosis in Non-alcoholic Fatty Liver Disease10966 Kutsenko Alina Heterogeneity among Asians with Hepatocellular Carcinoma (HCC): A Single Center Study in California10967 Kutsenko Alina Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma in Maritime South East Asians10652 Kutu Muhammet Hepatitis B Surface Antigen Monitorization during Oral Antiviral Therapy10825 Kuwashiro Takuya Extracellular Matrices Impair the IFN-a Signaling Via the Beta 1 Integrin-Mediated Signaling11375 Kwak Ye Eun Lack of Contrast Washout in Delayed Phases in Hepatocellular Carcinoma with Portal Vein Occlusion10042 Kwee Sandi A. Specific Phosphatidylcholine Species are Associated with Liver Tumors Detected by 18F-Choline PET/CT10521 Kwo Paul Elbasvir/Grazoprevir in Cirrhotic Patients with HCV Infection10523 Kwo Paul Predictors of Response to Elbasvir/Grazoprevir In HCV Genotype 1-Infected Patients10651 Kwon So Young Tenoforvir Disoproxil Furmarate is Effective and Safe for Lamivudine-Resistant HBV Infection 20171 Lada Olivier HBsAg Variability on Response to Pegylated-Interferon plus Tenofovir Combination Therapy11076 Laffitte Bryan A Novel, Highly Potent, Non-Bile Acid FXR Agonist for the Treatment of NASH and Cholestasis11078 Laffitte Bryan Anti-Fibrotic Effect A Novel, Non-Bile Acid FXR Agonist in A Model of Non-Alcoholic Steatohepatitis10729 Lai Ching Lung An Integrated Analysis of Phase 2,3 SOF and LDV/SOF Trials for the Treatment of GT6 HCV Infection10824 Lai Ching-Lung Placebo-Controlled Trial of Antibody to Connective Tissue Growth Factor (CTGF) in HBV Liver Fibrosis10180 Lai Jennifer Polypharmacy and Medication Adherence in Liver Transplant Candidates10181 Lai Jennifer Non-Selective Beta-Blockers and Physical Function10690 Lai Jennifer Patterns of Disability on the Liver Transplant Waitlist: from the FrAILT Study11042 Lai Keng Cost-Effectiveness of Rescue Therapies for LAM-Resistant Patients with HBeAg-Positive CHB10209 Lal Dewa Pakshage Chula Kanishka Ananda Hepatic Actinomycosis Mimicking Hepatocellular Carcinoma10210 Lal Dewa Pakshage Chula Kanishka Ananda Hepatitis B Vaccination among Dental Practitioners in Sri Lanka10515 Lashen Sameh A. Target of Rapamycin and Autophagy in Chronic Hepatitis C Infection:Relation to Disease Activity10868 Lawitz Eric Ledipasvir/Sofosbuvir Regimens for the Retreatment of Patients Who Failed Sofosbuvir-Based Regimens 10196 Lebensztejn Dariusz M. Fibroblast Growth Factor 21 Concentration in Obese Children with Nonalcoholic Fatty Liver Disease10782 Leblebicioglu Hakan Chronic Liver Disease and Crimean Congo Hemorrhagic Fever: Two Overlapping Disorder10589 Lee Guan-Huei Liver Transplantation for Patients with Acute-on-Chronic Liver Failure in Asia11019 Lee Hae Lim Acute Hepatitis and Reactivation of Hepatitis C Virus in Patients under Immunosuppressive Therapy10613 Lee Hae Won The Start of Liver Transplantation at the Public Hospital in Korea11139 Lee Hye Won Distribution of Quantitative HBsAg Level According to Serum HBV DNA Level in Chronic Hepatitis B11130 Lee Hyeseung ELK4, SIRT7 and H3K18ac Expressions in Hepatocellular Carcinoma with Prognostic Implication10838 Lee Jin-Woo Impact of Antiviral Treatment on Clinical Outcome after Curative Therapy for Hepatitis B Related HCC10485 Lee Jonathan W. Health Perceptions Amongst Patients with Fatty Liver - A Weighty Issue20103 Lee Joo Ho Proteomic Analysis for Identification of Biomarkers in Non-B, Non-C Hepatocellular Carcinoma10962 Lee Jung Il The Effect of Additional TACE after Combined Chemoradiation for Locally Advanced HCC with PVT10581 Lee Mei-Hsuan Genetic Variants Near HLA Gene were Associated with the Risk for HCC among HCV Infected Patients10950 Lee Myungseok A Family with Four Siblings Affected with Primary Biliary Cirrhosis11147 Lee Sam CC-31244, A Pan-Genotypic, Potent HCV NS5B Non-Nucleoside Polymerase Inhibitor10678 Lee Shou-Wu The Association of Non-Alcoholic Fatty Liver Disease with Metabolic Syndrome10702 Lee Shou-Wu Two-Year Real Life Data of Tenofovir Disoproxil Fumarate to Chronic Hepatitis B Patients in Taiwan10905 Lee Taeheon Accessment of Response by Elastography during the Tenofovir Treatment in Hepatitis B Patients11022 Lee Terence C-Terminal Truncated Hepatitis B Virus X Protein Regulates Stemness Via Stat3/Nanog Pathway11188 Lee Yong Kang Clinical Outcomes of DEB-TACE Versus Conventional TACE in Hepatocellular Carcinoma10419 Lee Young-Sun Systematic Review : Steroid, Pentoxifylline or Combined Therapy for Acute Alcoholic Hepatitis10580 Leroy Vincent Daclatasvir + Sofosbuvir + Ribavirin for HCV GT-3 with Cirrhosis or Advanced Fibrosis: ALLY-3+ Study10278 Lesmana Cosmas Rinaldi Clinical Pattern of HCC in A Single Hospital : A Report of 226 Cases 11040 Leung Jonathan C. F. Histological Severity and Clinical Outcomes of Non-Obese Non-Alcoholic Fatty Liver Disease 11215 Li Bing Cost-Effectiveness Analysis of Sofosbuvir plus Ledipasivir CHC GT1b- Real Life Practice in China11210 Li Fan Cost-Effectiveness Analysis of Sofosbuvir-Based Regimens for CHC GT2-Real Life Practice in China10271 Li Huashan The Impact of Nucleos(t)ides Analogues on the Renal Function in Patients with Chronic Hepatitis B20019 Li Jie Relationship between Serum HBsAg Level and Intrahepatic cccDNA under Different Serum HBeAg Statuses20072 Li Lei Effects of UDCA on Bile Secretion in Patients with Cholestasis10497 Li Mei Effect of Polydatin to ApoE-/- Mices the Expression of MDA/T-SOD and Liver Function10592 Li Mei The Value of HBV-PreS1 and Other HBV Antigens for Hepatitis B Virus Associated Glomerulonephritis10593 Li Mei Expression and Significance of HBeAg, HBV-DNA in the Patients with HBV Associated Nephropathy10598 Li Mei Change in Renal Pathological of HBV-GN and NHBV-GN11206 Li Wanyu Liver Transplantation in Primary Biliarycirrhosis: A Retrospective Cohort Study10311 Li Weiquan James Assessing Fibrosis Regression in Treated Hep B Using Transient Elastography and LiFa-HBV Score11282 Li Xiangyong Combination of LdT and ADV is Efficacious and Safe for CHB Patients with LAM/LdT Experience11285 Li Xiangyong Combination of LdT and ADV is Efficacious and Safe for CHB Patients Who Failed LAM/ADV/LdT Treatment

11275 Li Xiangyong Combination of ADV and ETV Therapy is Effective in CHB Patients Who Failed to ADV Monotherapy11279 Li Xiangyong Entecavir Treatment for Patients with Hepatitis B-Related Cirrhosis is Efficacious and Safe11280 Li Xiangyong De Novo LAM and ADV Combination Treatment in CHB Patients with High HBV DNA Level is Efficacious10120 Li Xu The Changes of Liver Stiffness and Its Associated Factors for CHB Patients with Antiviral Therapy10718 Li Yao Do Unfavorable rtM204I/V and sW182stop/rtV191I Mutations Trend to Co-Mutate in Genotype C HBV?10389 Li Yong IFN&alpha Mediated Excision Repair Pathway Correlates with Antiviral Response Against HBV Infection10338 Li Yuanyuan Risk-Factors for Mortality in PBC Patients: A Deceased Case-Living Control Study in China10935 Li Yutang Characterization of Serum HBV RNA in Untreated HBeAg-Positive Chronic Hepatitis B Patients10240 Liang Kung-Hao GALNT14 Genotype Correlates with Cholangiocarcinoma Features, Chemoresponse and Overall Survival10474 Liang Ling-bo HBV cccDNA Correlates with Histological Immflammation Activity in Chronic Hepatitis B Infection10839 Liang Yujiao Comparison of HBV Variants by Deep Sequencing with PCR and without PCR10092 Liao Chien-Chang Risk and Adverse Outcomes of Fractures in Patients with Liver Cirrhosis: Two Nationwide Studies10621 Liao Chien-Chang Risk and Adverse Outcomes of Stroke in Patients with Liver Cirrhosis: Two Nationwide Studies10034 Liao Kuan Fu Zolpidem Use Associated with Increased Risk of Pyogenic Liver Abscess10208 Lim Ming Han Reliability of Transient Elastography for the Detection of Fibrosis in Severely Obese Patients.10398 Lim Yoo Li Acute-on-Chronic Liver Failure Development Correlate with Baseline Portal Hypertension10837 Lim Young-Suk Tenofovir Monotherapy up to 96-Weeks in Patients with Adefovir-Resistant Chronic Hepatitis B20063 Lin Biaoyang CHI3L1 is A Liver-Enriched, Noninvasive Biomarker for Staging and Diagnosing Hepatic Fibrosis10163 Lin Chih-Lang Intrahepatic HCV RNA and Genotype 1 Independently Associate with Hepatic Reticulon 3 Expression10376 Lin Chih-Wei ABT-493 and ABT-530 Pharmacokinetics are Similar in Healthy Japanese, Chinese and Caucasian Adults10114 Lin Chih-Wen Alcoholism Concomitant with Viral Hepatitis Increases the Prevalence of HCC in Taiwan10798 Lin Guoli The Epidemiological Characters of the Patients with HBV HCV Co-Infection10857 Lin Guoli the Virological Data of the Patients with HBV-HCV Co-Infection

Submission No. Last Name First Name Title of Abstract10861 Lin Guoli The Virological Response of the Patients with HBV-HCV Co-Infection after Accepting Anti-HCV Therapy 10309 Lin Huiyu A Case Hepatic Rupture in Acute Fatty Liver of Pregnancy 10489 Lin Huiyu A Rare Case of Levothyroxine-Induced Liver Injury 10020 Lin Kwang-Huei Thyroid Hormone-Activated DAPK2 Suppresses Hepatocarcinogenesis Through Autophagy20066 Lin Yen-Chih Influence of Soil Heavy Metals in Fatty Liver Disease 10318 Lin Yu-Tung The Correlation between Serum Zinc Level and Dysgeusia in Cirrhotic Patients10790 Liu Chen-Hua Peginterferon plus Ribavirin for HIV-Infected Patients with Acute or Chronic HCV Infection in Taiwan10448 Liu Jessica The Association between SNPs on ADH1B and ALDH2 and HBV Related HCC is Mediated by Alcohol Drinking

10459 Liu Jessica Hepatitis B Core Antibody Levels Can Predict HBeAg Seroclearance in Chronic Hepatitis B Patients 10562 Liu Peter P. Metabolic Syndrome as Predictors for Severity of NAFLD Detected by Ultrasonography in Taiwanese11016 Liu Sze Hang Kevin A Population-Based Study on the Seroprevalence of Viral Hepatitis in Hong Kong, China11165 Liu Tianhui Reversion of Liver Fibrosis after Anti-HBV Treatment for 52 Weeks is Closely Related to HBV Genotype11254 Liu Tianhui CYP2E1 Inhibitor DDC Upregulates MMP-13 Expression in Vivo Through Modulating miR-22211079 Liu XiuHong Evaluation of the Diagnostic Value of Plasma GP73 and AFP in HCC Patients Infected with HBV 11074 Liu Yali High Rate of Hepatitis B Surface Antigen Mutations in Chinese Patients with Chronic HBV Infection 11350 Liu Ya-Lin A Prospective Evaluation of Occult HBV Infection in Immunized Infants Born to HBsAg-Positive Mothers10168 Liu Yuhan Identification of SENP3 as A Potential Modulator in the Lipid Metabolism Pathway in NAFLD10821 Lo Sum Team Clinical Features and Survival of Non-Alcoholic Fatty Liver Disease-Related Hepatocelullar Carcinoma10875 Locarnini Stephen Mapping HBsAg Epitope Profiles Predictive of Seroclearance in Genotype A CHB Patients on TDF Therapy10784 Loh PY Audit of the Practice of Elective Endoscopic Variceal Ligation and Its Complication in Singapore10969 Loho Imelda M. Survival Rate of HCC Patients after Fifteen Years in A Tertiary Referral Hospital in Indonesia11261 Long Chen The Protective Role of TGF--Β Induced Upregulation of Follistatin against Mice Hepatic Fibrosis10170 Lozada Angelo B. Antifibrotic Effect of Oral NUCs in Chronic Hepatitis B Infection Assessed by Transient Elastography11169 Lu Fengmin HBV Pregenome RNA Virus is Associated with Persistence of HBV Infection and Viral Rebound11038 Lu Wei Optimized Therapy with Domestic Lamivudine and Adefovir in HBeAg-Positive Chronic Hepatitis B10192 Lui Ka Yin LncRNA INTS6P1, A Prognostic Factor in HCC, Induces Apoptosis Via Intrinsic Mitochondrial Pathway11145 Lv Ting-Xia Mutation Analysis of HFE Gene in A Small Cohort of Hereditary Hemochromatosis Cases from North China10351 Ma Anlin Liver Stiffness Measured by Transient Elastography is Superior to APRI and FIB-4 in CHB Patients10925 Ma Hui HBcrAg is A Predictor of HBeAg Seroconversion in CHB Patients Treated with Pegylated Interferon 11018 Ma Stephanie Functional Role of TP53INP1 in HCC Metastasis10348 Maekawa Shinya Detecting NS5A-Y93H Mutations and Analyzing its Clinical Significance in HCV-1b Patients10978 Maeno Hiroshi A Case of the Large Hepatocellular Carcinoma Effective Treatment with Modified NEW FP Method11096 Maevskaya Marina V. The Automated System for Screening of Liver Disease 10627 Magsino Ermil R. Corticosteroid Therapy in Relapsing Hepatitis A: A Case Report20018 Magsino Ermil R. D.I.Y. Dual Purpose Gastro-Enteric Tube(Simultaneous Gastric Decompression and Enteral Feeding)11067 Mahajan Vipul Meta-Analysis: Geographical Variation in Treatment Rates of Chronic Hepatitis B (CHB) Patients10659 Maharshi Sudhir Effects of Nutritional Therapy on Complications and Outcome in Cirrhosis - Randomized Trial10051 Mahtab Mamun-Al Comparison between HVPG and Endoscopy of UGIT in Assessing Severity of Portal HTN in Cirrhotics10052 Mahtab Mamun-Al Fibroscan is Superior to HVPG in Assessing Advanced Hepatic Fibrosis10053 Mahtab Mamun-Al RVR Response in HCV Related Decompensated Cirrhosis with Sofosbuvir in Bangladesh10054 Mahtab Mamun-Al RVR Response in HCV Related Compensated CLD with Triple Therapy Containing Sofosbuvir in Bangladesh

10055 Mahtab Mamun-Al Safety and Efficacy of Stem Cell Stimulating Therapy in Decompensated Cirrhosis of Liver10056 Mahtab Mamun-Al Comparison of LdT vs ETV in Patients with Hepatitis B Related ACLF in Bangladesh10760 Mahtab Mamun-Al NASH Challenges HBV as the Leading Cause of Chronic Hepatitis in Bangladesh10763 Mahtab Mamun-Al Hepatitis B Virus Remains the Leading Cause of Cirrhosis of Liver in Bangladesh10956 Mahtab Mamun-Al Hepatitis B Virus Remains the Leading Cause of HCC in Bangladesh11256 Maiwall Rakhi Natural History and Outcome of Stage3 AKI in Patients with ACLF-A Multinational Cohort Study11085 Majumdar Kaushik Progenitor Repopulation by K7, K19 and Glutamine Synthetase Expression in Hepatic Vasculopathies10279 Makino Yuki Significance of the up-Regulation of Connective Tissue Growth Factor in Hepatocellular Carcinoma10185 Malbog Milben A. Incidence of Drug Induced Liver Injury in Government Hospital Patients on Anti-Koch's Treatment10503 Mandai Mari Usefulness of Radiofrequency Ablation for the Elderly with Hepatocellular Carcinoma10517 Manns Michael P. Safety and Tolerability of Elbasvir/Grazoprevir in Chronic Hepatitis C Infection11125 Manns Michael P. Safety and Efficacy of Hepatitis C Genotype 1b Oral Regimens: HCV-Target Interim Analysis 10658 Mantri Alok Renal Abnormalities in Patients with Chronic Hepatitis C and Response to Therapy10212 Mao Xiaowen Functional Role of Caveolin-1-Mediated S100P Signaling in Liver Cancer Metastasis under Hypoxia10781 Maruno Ayako A Case of Autoimmune Hepatitis Successfully Treated with Ursodeoxycholic Acid11080 Massry Alaa eldeen Male Patient with Anaphylactic Shock And Hepatic Cyst10298 Matsui Daigo Sorafenib Might Inhibit Liver Fibrogenesis in Patients with Cirrhosis and Hepatocellular Carcinoma10945 Matsui Takeshi The Efficacy of Warning Popup System in Electronic Medical Chart in Screening for HBV Reactivation11106 Matsumoto Naoki Renal Vein Dilation Predicts the Prognosis of Cirrhotic Ascites10955 Matsumoto Nobuyuki Hemoglobin Decrease with Iron Deficiency Induced by DCV/ASV Therapy for Chronic Hepatitis C10191 Matsumoto Tomonori Expression of Activation-Induced Cytidine Deaminase in Hepatocytes under Immune Response against HBV10475 Matsumoto Toshihiko Collagen Matrix Modulates Macrophage Expression of MMPs in Part by Controlling Cell Shape10916 Matsunami Kayoko Genome-Wide Association Study on Genetic Variants Associated with Interferon-Induced Depression10471 Mawatari Seiichi the Association between the Efficacy of Dual Oral Therapy for HCV and Resistance-Associated Variants11138 McPhee Fiona High SVR with DCV+ASV in HCV GT-1b Chinese, Koreans & Taiwanese without Baseline NS5A Polymorphisms

20097 Mehmood Rabia Variations in Red Cell Indices and Protein Profiling Due to the Exposure of Metallic Dust11332 Meng Fanping PTP-PEST Controls Liver Cancer Cell Migration Through Regulation of RhoA and Rac111114 Meng Fanyin Functional Role of microRNAs-FoxA2 Axis in Cholestatic Liver Injury20012 Meng Jing Hospital Epidemiology of Hepatitis B Virus Infection20013 Meng Jing Hemochromatosis with A Novel Mutation of SLC40A1 Gene in China:a Case Report10153 Meric Koc Meliha Febrile Neutropenia Associated with Hepatitis B Infection: A Case Report10819 Mert Duygu In A Patient Who is HBsAg-Negative and AntiHBs Positive , Reactivation of Hepatitis B Infection 10899 Messina Vincenzo HBV,HVC,HIV Prevalence.Evaluation in A High Risk Population (1999-2014)10403 Mikamori Manabu Clinical Significance of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma11338 Mikata Rintaro EUS-Guided Ethanol Injection for Hepatocellular Carcinoma in S1 Region10159 Miki Daiki Japanese Genetic Study Could not Suggest the Importance of the NTCP Locus for HBV Persistence10312 Minami Masahito Reappearance of Hepatitis C Virus Accompanied by Genotypic Change after Sustained Viral Response10454 Minami Tomohiro US-US Fusion Imaging in Radiofrequency Ablation Therapy for Liver Cancer10404 Minemura Masami Analysis of the Direct Interaction between Macrophages and Microbiota10167 Mishra Amrish Hep B Prevention20104 Mitchell Todd Amatoxin Poisoning: Interplay of Renal Function, Lactate Values, IV Hydration and Silibinin11003 Miura Kotaro Assessment of Quality of Life of Japanese Patients with Primary Biliary Cirrhosis Using PBC-4011140 Miura Masateru The Comparison Examination with A Serum Sodium Level and Varicose Recurrence in Alcoholic Cirrhosis11146 Miyaaki Hisamitsu Significance of Hepatic Insulin Clearance in Patients with CHC and NAFLD11052 Miyadera Hiroko A Large Scale Screening of HLA-Binding Peptides from HBs and HBc Peptide Libraries

Submission No. Last Name First Name Title of Abstract10239 Miyagawa Koichiro Lipid-Induced Endoplasmic Reticulum Stress Impairs Selective Autophagy in Hepatocytes10442 Miyata Akinori Detection of Small Liver Tumors Using Intraoperative Real-Time Virtual Sonography10385 Miyazaki Masayuki Efficacy of Sofosbuvir/Ribavirin for Japanese Patients with HCV Genotype 2 Infection10662 Miyazaki Teruo Serum 3-Hydroxyisobutyrate as A Biomarker of Muscular BCAA Catabolism in Liver Cirrhosis Patients10551 Miyazaki Tsuneyuki Sodium Alginate Prevents NASH Progression and Liver Carcinogenesis in Obese and Diabetic Mice10063 Miyazoe Yuri Relation of the Nucleoside Analogues Therapy and HBsAg in Patient with Hepatitis B Virus Related HCC10740 Mizokami Masashi Asian Genotype 1 HCV Achieve 99% SVR with 12 wks of LDV/SOF: Analysis of Phase 3 Multicenter Studies

10878 Mizokami Masashi Characterizing Resistance in Patients Receiving SOF or LDV/SOF in Korea, Japan, and Taiwan10330 Mo Fan Efficacy and Safety of Telbivudine in Treatment Naive or ADV Treated HBeAg Positive CHB Patients 10928 Mo Ling FSS and SF-36 in Asian Patients with HCV G1 b Receiving DCV+ASV and IFN+RBV Intolerant/Ineligible10524 Mohammed Tahiri Joutei Hassani VBT: A New Test of Variceal Source among Patients Presenting with Upper GI Bleeding11103 Mohebbi Seyed Reza Detection of TTV in Iranian Patients with HBV or HCV Monoinfection, HIV and HCV Coinfection11239 Mohebbi Seyed Reza Association between A Polymorphism in microRNA Target Site of Interleukin 16 and Chronic Hepatitis B11304 Mohebbi Seyed Reza Lack of Association between IL-12RB1 Gene Polymorphism (rs11575934) and Chronic Hepatitis B11321 Mohebbi Seyed Reza Parvovirus 4 Infection in Iranian HCV Infected Patients and Healthy Individuals 11331 Mohebbi Seyed Reza Polymorphisms of Interleukin 12 Gene are not Associated with Chronic Hepatitis B in Iranian Patients20042 Mohite Ashok R. Changing Clinical Profile of Liver Enzyme Abnormalities among HIV-Infected Persons10331 Morikawa Kenichi Analysis of Cellular Factors Involved in the Particle Formation and Secretion of Hepatitis C Virus11014 Morimoto Manabu Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma: Short-Term Efficacy10149 Morimoto Naoki Evaluation of Laparoscopic Multipolar Radiofrequency Ablation for Localized Hepatocellular Carcinoma10752 Moriya Akio Factors Associated with the Increase in FIB-4 Score: A Longitudinal Study10319 Mukozu Takanori Molecular Target Drug (Sorafenib) Might Cause the Activation of Kupffer Cell10225 Murata Kazumoto Induction of IFN-λ3 by ADV or TDF in HBV Patients 10951 Murayama Asako Host Factors for HCV Replication and Infectious Virus Production in Vero Cells10437 Murayama Kenichiro Hepatic Arterial Infusion Chemotherapy vs Sorafenib for cTACE-Refractory HCC10681 Muroyama Ryosuke Fusion HBx from HBV Integrant Might Affect ER Stress Response and be Associated with HCC11293 Musabaev Erkin Diagnostic Importance of ccc DNA in Patients with Chronic Hepatitis D10302 Muthiah Mark D Reducing the Rates of Invasive CMV Disease in Post Liver Transplant Patients.10788 Mutlu Yilmaz Esmeray Stigma, Discrimination and Living with Hepatitis B in Turkey11105 Na Seong Kyun ALBI Grade vs. Child-Pugh Grade as A Grading System for Liver Function in Patients with HCC10099 Nababan Saut Ether Phospholipid Profile in Mice with Non-Alcoholic Steatohepatitis10157 Nagano Tomohisa Impact of Chronic HCV G1b Infection on TG Concentration in Serum Lipoprotein Fractions10195 Nagaoka Katsuya Integrative Analyses of Multi-Omic Data of Histone Demethylase LSD1/2 in Liver Cancer Cells10368 Nagaoki Yuko Efficacy and Safety of Danaparoid Sodium Followed by Warfarin or Edoxaban for Treatment of PVT10604 Nagashima Shintaro Characteristics of HBV Full-Length Sequences in 21 Persons among 509 Residents in Binh Thuan,Vietnam20017 Nagata Hiroko Serial Changes in M2BPGi Levels as Predictors of Fibrosis and HCC in Chronic Hepatitis C11032 Nah Yang Won Surgical Results of Outflow Reconstruction in Living Donor Liver Transplantation10469 Naito Yoshiki Recurrence of Intraductal Papillary Neoplasm of the Intrahepatic Bile Duct: Report of Two Cases10244 Nakagawa Hayato Novel Mouse Model of NASH-Driven HCC Whose Progression Depends on TNF-IKK Pathway20001 Nakagawa Ryo Decreased miR-425 Induced Inflammatory Cytokine Production in Primary Biliary Cholangitis11349 Nakagawa Tomoo A Case of Liver Tumors Caused by Lymphoproliferative Disorder in Crohn's Disease Clinical Course10198 Nakagiri Kenta Adipose-Derived Stem Cell Administration for Cytotoxic T Lymphocyte-Mediated Liver Injury in Mice11176 Nakagomi Ryo Sequential Measurement of Liver Stiffness in Patients with HCV with or without Sustained Response10387 Nakajima Tomoaki Change of AFP Level According to the Stage of Liver Disease during Daclatasvir/Asaunaprevir Therapy10948 Nakamoto Shingo Association between Sirtuins Expression and Hepatocellular Carcinoma10686 Nakamura Masato Lower Circulating microRNA-122 Indicate Severe Hepatic Fibrosis in Chronic Hepatitis B Patients10369 Nakamura Toru Ex Vivo Expanded Circulating CD34+ Cells Exhibit Potent Therapeutic Effect on Liver Cirrhosis

10396 Nakano Masahito Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis10535 Nakayama Goichi A Case of Hematogenous Metastic Small Intestinal Tumor of Hepatocellular Carcinoma11276 Nakayama Nobuaki Acute Liver Failure Due to HBV Reactivation Via Immunosuppressive or Anticancer Therapies in Japan10843 Nam Hyeong Seok Percutaneous Cholecystostomy as Definite Management for Acute Cholecystitis with Klastin Tumor20117 Nam Joon Yeul Oral Medications Improve Overall Survival by Enhancing Compliance to Surveillance for HCC10845 Nam Hyeong Seok Efficacy of Minor Endoscopic Sphincterotomy to Prevent Post-ERCP Pancreatitis for Biliary Stenting 10612 Namisaki Tadashi Liver Fibrosis Progression Only Predicts Survival and Ursodeoxycholic Acid Response in PBC Patients10614 Naoe Hideaki Proteomics Analyses Identified A Phosphoprotein Relevant to Apoptosis Resistance in Human Hepatoma20050 Nautiyal Prachi Innovative Information-Education-Communication Strategies on Hepatitis B 10345 Nawa Takatoshi Hepatitis C Virus Infection Reduces Chemo-Sensitivity of the Hepatocellular Carcinoma Cells 11300 Nersesov Alexander Some Clinical Associations of Thrombocytopenia in Liver Disease of Different Stages and Etiologies 11057 Nguyen Pauline Rising Inpatient Hospital Charges(IHC) in Ethnically Diverse U.S. Chronic Hepatitis C(CHC) Patients10682 Nguyen Toan B. Value of AFP, AFP-L3 and DCP in Early Detection of Hepatocellular Carcinoma in Vietnamese Patients10780 Ni Yen-Hsuan Hepatitis B Virus Infection Decreases to A Minimal Extent after 30-Years' Universal Vaccination 11137 Nihei Takeshi Comparison of 'Low MI THI' Mode and CHI Mode in Contrast-Enhanced Ultrasonography of Liver Tumors11087 Niikura Toshihiro A Case of Recurrent HCC with Bile Duct Invasion Effectively Treated by Cyberknife11379 Ning Ling Prevalence of Chronic Kidney Disease in Patients with Chronic Hepatitis B: A Cross-Sectional Survey10424 Nishimura Norihisa Ipragliflozin Ameliorates Liver Fibrosis Development in Diabetic OLETF Rats11013 Nishimura Takashi Pathogenesis of Portal Hypertension and the Intrahepatic Hemodynamics in Liver Cirrhosis10044 Nishina Sohji DPP-4 Inhibitor, Anagliptin Suppresses the Progression of Hepatocellular Carcinoma10886 Nishina Taketo Sofosbuvir plus Ribavirin Treatment in Genotype 2 Infection in Japanese Real World20008 Nitta Sayuri In Vitro Characterization and Drug Sensitivity Analysis for HCV NS5A Resistance-Associated Variants10863 Noguchi Ryuichi Serum ACE Level as A New Non-Invasive Fibrosis Marker Could be Possible for HBV Patients10848 Nomura Sayuri Efficacy and Side Effects of SOF/RBV in Patients with Hepatitis C Virus Genotype 2 Infection10048 Noor-E-Alam Sheikh Mohammad Limited Implication of Ratio of Serum AST to Serum ALT for Diagnosis of NASH10900 Nuta Junya Kupffer Images of Contrast Ultrasound and Recurrence after Hepatectomy for Hepatocellular Carcinoma10832 Obi Shuntaro NLR is Predictive Factor for Survival in Patients with Advanced HCC Treated by Sorafenib20166 Obi Shuntaro Hyponatremia is Prognosis Factor of Refractory Ascites 10356 Ochi Yuka SNPs are Associated with Pathogenesis of Chronic HBV Infection10924 Ochirkhuree Bayarmaa Assessment of Minimal Hepatic Encephalopathy in Mongolia10499 Oda Kohei The Association between sAIM and the Clinical Features of Non-Obese Patients with NAFLD10391 Oe Shinji Involvement of Endoplasmic Reticulum Stress in Excess Copper-Induced Hepatotoxicity10232 Oeda Satoshi Surveillance of Viral Hepatitis Affects not Only the Detection of Early-Stage HCC but Also Survival10953 Ogasawara Sadahisa Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Resistant to Sorafenib20172 Ogasawara Sadahisa Liver Function Assessment According to the ALBI Grade in Sorafenib-Treated Advanced HCC Patients 11260 Ogata Kei The Clinical Profiles of Patients with L31 and Y93 aa Variants in NS5A Region of Hepatitis C Virus11143 Ogawa Chikara New Fusion Techlology; Colorezid RVS10169 Ogawa Eiichi Impact of HCV Kinetics Differs by the Type of Real-Time Assay Used to Monitor Triple Therapy 10276 Ogawa Eiichi Efficacy of Second-Generation Protease Inhibitor-Based Triple Therapy for HCV Genotype 1b Patients


Submission No. Last Name First Name Title of Abstract10992 Ogura Suguru The Role of Hematopoietic Stem Cells in Liver Pathogenesis20015 Ogurtsov Pavel Blood Group and IL-28B Genotype in PEG-IFN-&Alpha and RIBAVIRIN Therapy for HCV-1 and Liver Fibrosis

10040 Oh Myung Jin Differentiation in Patients with Acute Hepatitis B and Chronic Hepatitis B with Acute Exacerbation10200 Ohara Tomomi Therapeutic Effects of Ghrelin and Leptin on Experimental Acute Liver Injury in Mice.10187 Ohkawa Kazuyoshi Subclassification of BCLC Stage B Hepatocellular Carcinoma Using up-to-7 Criteria and Tumor Markers10246 Ohki Takamasa The True Efficacy of Tolvaptan in Patients with Refractory Ascites10249 Ohki Takamasa Tolvaptan Improved Refractory Ascites and Overall Survival in Patients with Hyponatremia10256 Ohki Takamasa the Effectiveness of Cyber-Knife Therapy for Lymph Node Metastasis from Hepatocellular Carcinoma10257 Ohki Takamasa TACE Followed by Sorafenib Improves Progression Free Survival in Patients with Advanced HCC20165 Ohki Takamasa RFA for Metastatic Liver Tumor Due to Colorectal Cancer A Retrospective Matched Control Study11065 Ohta Yuki Sofosbuvir plus Ribavirin Treatment for HCV-Infected Patients with Ulcerative Colitis10964 Oikawa Takayoshi The Short-Term Effectiveness of TACE Using Cisplatin-Eluting Hepasphere for Unresectable HCC10854 Okabe Junya Measurement of Liver Fat Volume by Multi-Material Decomposition Method with Dual Energy CT in NAFLD

10227 Okada Michiaki Advice of Doctors and Surrounding People Influence Decisions on Hepatitis Screening and Treatment10447 Okamoto Toshiaki The Antifibrotic Effects of Endothelin Type A Receptor Antagonist in NASH Model FLS-ob/ob Mice10111 Okamura Yukiyasu The FIB-4 Index is A Prognostic Predictor for Non-B Non-C Hepatocellular Carcinoma11359 Okan Asli The Reduction of HBV DNA Levels at the Third Month for Predicting Virological Response 10320 Okubo Hironao Gadoxetic Acid Enhanced MRI Predicts Hyperbilirubinemia of Simeprevir in Patients with HCV10829 Okubo Tomomi Elderly and Low Serum 25(OH)D3 Level Contributes to Drug Resistance of NS5A Region10754 Okumoto Kazuo Efficacy and Safety of Cisplatin vs Doxorubicin in TACE for HCC10374 Okumura Shinya Impact of Preoperative Sarcopenia on Outcomes after Resection of Biliary Cancer11360 Olczak Anita Genotype Distribution of Hepatitis C Virus in HIV Infected Patients in Bydgoszcz, Poland20016 Oliman Michael John A. The Use of Silymarin in Chronic Hepatitis C Infection: Updated Systematic Review and Meta-Analysis10726 Omata Masao Asian Patients with GT 2 HCV Achieve 98% SVR with 12 Weeks of Sofosbuvir & Ribavirin20157 Omata Masao Treatment of Patients Over Age 80 by Sofosbuvir20158 Omata Masao Influence on eGFR Less Than20159 Omata Masao Surprisingly Immediate Reduction of Serum AFP Level20160 Omata Masao No Influence on HbA1c Level20161 Omata Masao Long Term Effect of HCV Eradication on Serum Lipids10789 Omichi Kiyohiko Postoperative Outcomes for Patients with HBcAb-Positive Non-B Non-C Hepatocellular Carcinoma11306 Ong-Chu Michelle C. Prevalence of Hepatitis B and C and Risk Factors among Prison Inmates in Cebu, Philippines10463 Ono Kohei A Case of Congenital Hepatic Fibrosis Leading to Hepatocellular Carcinoma11273 Ooka Yoshihiko The Benefit of Balloon Occluded TACE Compared with Conventional TACE for BCLC Stage B HCC Patients

11160 Ormeci Necati Natural Course and Etiology of End-Stage Liver Disease in Turkey11248 Ormeci Necati CHB Patients Long term Followed Up For Cirrhosis & HCC Development under Tenofovir Treatment10509 Osaki Rie A Summary of Using Levocarnitine with Liver Cirrhosis in Our Hospital11011 Osawa Yosuke Inhibition of CBP/Β-Catenin Reduces Liver Fibrosis in Mice10381 Osman Osman A. Role of Fluorescence in Situ Hybridization in the Diagnosis of Malignant Biliary Stricture10757 Osuga Tatsuya Aspirin Administration May be A Therapeutic Option for Cirrhosis-Related Thrombocytopenia10273 Ozaras Resat Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis10283 Ozaras Resat Psoriasis and Neutrophilic Cholangitis: More Than A Coincidence10644 Ozaras Resat Acute Hepatitis A May Trigger Development of Autoimmune Hepatitis 10738 Ozbakir Omer Endothelial Dysfunction in Cirrhosis and Hepatorenal Syndrome10771 Ozdil Kamil Comparison the Accuracy of Clinical Assessment Tools to Diagnose Malnutrition in Cirrhosis10468 Ozeki Itaru HBsAg Analysis Using the Highly Sensitive Lumipulse HBsAg-HQ Assay in Patients with Liver Disease10473 Ozeki Itaru Evaluation of Hepatitis B Surface Antibody and Core Antibody in Patients with HBsAg-Negative10104 Ozturk Kadir The Association of Non-Alcoholic Fatty Liver Disease with Obesity and Apolipoproteins10677 Ozturk Kadir A Rare Case: An Elderly Women with Type 3 Choledochal Cyst20036 Ozturker Coskun Is Diffusion MRI A Useful Tool for Evaluating Liver Fibrosis?20041 Ozturker Coskun Acute Fatty Liver of Pregnancy Mimicking Acute Cholecystitis 20149 Ozturker Coskun Performance of Acoustic Radiation Force Impulse in Patients with Chronic Hepatitis B10866 Palgova Liudmila K. Obstetric Complications in Obese Pregnant Women, Associated with Liver Steatosis10241 Pan Xiao-Ben Inhibition of HBV cccDNA Transcription by CPP-PNA Conjugates Assembled on Oligonucleotide Scaffolds10307 Panasiuk Anatol Serum Transferrin Isoforms in Liver Diseases20174 Pande Gaurav SCALFI±Terlipressin Mobilizes Refractory Ascites Safely in Decompensated Liver Cirrhosis10097 Pandeya Dipendra R. Gut Microbiota and Their Metabolic Influence in Neonatal Intestine by Early Colonization 10337 Panlilio Mara Teresa T. NAFLD in Type 1 Diabetes Mellitus: Prevalence and Association with Metabolic Syndrome and CVD10089 Park Jihye Effects of ETV or TDF on Renal Function in Patients with HBV-Related Cirrhosis: Outcome at 2 Years 10712 Park Jung Gil Tenofovir and Entecavir for Patients with Chronic Hepatitis Resistant to Adefovir and Entecavir10811 Park Min-Su The Association between Tumor Necrosis Factor-Alpha Polymorphism and Acute Solid Organ Rejection10976 Park Na Ri TGF-β1 Enhances EMT in CD44 HCC Cell Lines, Leading to Cancer Progression and Metastasis.10646 Park Neung Hwa Inactivating Mechanism of ATBF1 Gene in Hepatocellular Carcinomas10647 Park Neung Hwa Genetic Alterations of the SIAH-1 Gene in Hepatocellular Carcinomas11033 Park Seung Ha Added Value of New Biomarkers Over APRI in Hepatitis B-Related Fibrosis10128 Parkash Om Clinical Characteristics and Outcome of Budd-Chiari Syndrome at A Tertiary Care Hospital in Pakistan10009 Parvez Mohammad K. In Vitro Evaluations of Anti-Hepatitis B Activities of 60 Medicinal Plants Extracts 20031 Parvez Mohammad K. In Vitro Hepatoprotective and Anti-Hepatitis B Activitis of Cyperus Rotundus Tuber Fractions 20040 Parvez Mohammad K. A Replicon-Baculovirus Model for Efficient Packaging of HEV RNA and Production of Infectious Virions10731 Patel Keyur Sofosbuvir/Velpatasvir for 12 wks versus 12wks of Sofosbuvir+Ribavirin in GT2 HCV: the ASTRAL-2 Study20062 Pawlowska Malgorzata Effect of Entecavir Therapy in 50 Children with Chronic Hepatitis B in Real Life Longitudinal Study10772 Peng Cheng Inhibitory Effect of miR-125b on HCV Core Protein- Induced TLR2/MyD88 Signaling in THP-1 Cells10229 Peng Kang-Yu Fatty Acid-Overloaded Steatotic Hepatocytes Display Altered Phospholipidome and Membrane Integrity10773 Peng Yuan Salvia Miltiorrhiza Enhances NK Cell Versus HSC Effect Via Modulating PD-L1/PD-1 Axis10310 Phisalprapa Pochamana Association between Caffeine Consumption and Nonalcoholic Fatty Liver Disease in Metabolic Syndrome10230 Pipaliya Nirav Comparison of Fibroscan with MRI R2* to Predict Liver Iron Overload in Thalassemia Major10807 Poovorawan Yong Impact of Universal Hepatitis B Vaccination into Newborn as Part of Thailand EPI Program Since 198820144 Prajapati Ritesh M. Granulocyte Colony Stimulating Factor Improves Survival of Patients with Decompensated Cirrhosis10464 Premkumar Madhumita A/H1N1/09 Influenza is Associated with High Mortality in Liver Cirrhosis10929 Premkumar Madhumita Presence of SIRS and Sepsis Predicts Mortality in Patients with Acute-on-Chronic Liver Failure.10938 Premkumar Madhumita Thromboelastography Accurately Interprets Coagulation Failure in Patients with ACLF10980 Pritchard-Jones Janice The Advanced Liver Disease Pilot Education Program for Nurses20028 Pugasub Alongkorn Urinary Peptidomics for Analysis of Proximal Renal Tubular Dysfunction in Chronic Hepatitis B10510 Pullukcu Husnu The Diagnosis of Leishmaniasis after Misdiagnosis Due to Hepato/Splenomegaly: A Review of 18 Cases10853 Pullukcu Husnu Hemophilia Patients' Level of Knowledge of about Viral Hepatitis 10215 Qi Yue Effect of Telbivudine on Intrahepatic cccDNA in HBeAg-Positive Patients with Chronic Hepatitis B11278 Qianyi Wang Comparison of FibroTouch and FibroScan for the Assessment of Liver Steatosis in NAFLD Patients

Submission No. Last Name First Name Title of Abstract20074 Qiao-yan GU The Relationship between Serum RPR and Hepatic Fibrosisin Male Nonalcoholic Fatty Liver Patients 10060 Qin Gang Comparison of Different Models in Predicting Prognosis of HBV-ACLF10747 Rabea Mohamed_Yossef Anti-CCP hs in Egyptian Rheumatoid Arthritis Patients Associated with Chronic HCV Infection.11236 Rabea Mohamed_Yossef The Risk of HBV and HIV Transmission in Long-Haul Truck Drivers in Egypt20114 Rakhmanaliev Elian Distribution of Resistance-Associated Variants (RAVs) in HCV Genotypes (GT) 1a and 1b Populations10013 Ramadan Ragaa A. Hypermethylation of Placental Bikunin Gene in Chronic Hepatitis C Virus Infection10014 Ramadan Ragaa A. Nitric Oxide: the Link between Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome 10706 Ranjan Arttrika Effect of Cytokine IL-18 on Different Phases of Chronic Hepatitis B Infection. Progression10777 Rashid Mohd Harun Or Impaired Liver Functions in Patients with Diabetes Mellitus in Bangladesh10801 Rashid Mohd Harun Or Dermatological Manifestations of Chronic Liver Disease10480 Rathi Chetan Drug-Induced Liver Injury at A Tertiary Care Hospital in India: Etiology, Presentation and Outcome11202 Rathi Sahaj Chronic Genotype 1 HEV Infection in An Immunosuppressed Liver-Transplant Recipient in India10727 Reddy K. Rajender Sofosbuvir Regimens are Safe and Highly Effective in Patients with Hereditary Bleeding Disorders10482 Reesink Hendrik W. Serum HBV-RNA Levels Decline Significantly in Chronic Hepatitis B Patients Dosed with REP2139-CA 10490 Reesink Hendrik W. PegInterferon Combination Therapy Versus No Treatment in HBeAg-Negative Low Viral Load CHB Patients10799 Ren Hong Switching to PegIFN Α&Ndash;2a in NUC Treated CHB Patients (NEW SWITCH Study): Comparison 48 and 96 Weeks

10774 Riani Risky I. The Role of Nutritions to Incidence and Severity of Non Alcoholic Fatty Liver Disease20093 Ricco Gabriele Etiology of Chronic Liver Disease and HCC Biomarkers20095 Ricco Gabriele Total Anti-HBc/IgM Anti-HDV Ratio Helps to Identify Patients with Severe HDV-Induced Liver Disease10550 Rim John H. Frequency and Distribution of Discrepant Anti-HCV Screening Results in Korea during Recent 4 Years10548 Rim John Hoon Spectrum of HBV DNA Drug Resistance Mutations in Korea: Is Heteroresistance of HBV Emerging?20154 Rinaldi Luca Early Changes of Liver Stiffness in HCV Patients Undergoing Treatment with DDAs: A Multicenter Study10724 Roberts Stuart K. Sofosbuvir/Velpatasvir for 12 wks vs Sofosbuvir+Ribavirin for 24 wks in GT3 HCV: the ASTRAL-3 Study11319 Rodriguez- Payan Natalia Succesful Percutaneous Thrombectomy for Portal Vein Thrombosis Following Liver Transplant10107 Rongqi Wang FibroTouch is Good for Evaluation of Liver Fibrosis in Chinese Patients with Chronic Viral Hepatitis11224 Rooge Sheetalnath Growth Factor Mobilized CD34+ BMSCs Rescue the Loss of Regenerative Microenvironment in Cirrhosis10361 Rtskhiladze Irakli Emergence of Hepatitis C Virus Genotype Recombinant Forms 2k/1b in Georgia10460 Ryu Tomoki Multiple Positive Tumor Markers Predict Poor Survival in Patients with Hepatocellular Carcinoma10439 Saeki Issei Efficacy of A New Therapeutic Assessment Score (ACTH score) for Advanced HCC Patients Receiving HAIC

11055 Saga Ryohei Bivalent Vaccine Antigen for Japanese Encephalitis Virus and Hepatitis C Virus10152 Saha Biplob Kumar Comparison between TDF vs TDF plus GCSF in Patients with ACLF-B in Bangladesh11119 Saito Koji Heterogeneity of Histological Features of Benign Hepatocellular Nodular Lesions20038 Saito Ryusuke A Case of Resection for Complete Spontaneous Regression of Hepatocellular Carcinoma10842 Saito Takafumi A Case of Intraductal Papillary Neoplasm of the Bile Duct Associated with Autoimmune Hepatitis10382 Sakai Hiroyasu the Role of the Phosphorylated RXRα on Diethylnitrosamine-Induced Liver Tumorigenesis in Mice10697 Sakai Takao Fibronectin Restricts TGF-Beta Bioavailability and Matrix Remodeling in Chronic Liver Fibrogenesis10186 Sakai Yoshio Clinical Trial for Regenerative Therapy of Cirrhosis Using Adipose Tissue-Derived Stromal/Stem Cells10720 Sakhinia Ebrahim Make the Best Decision Facing Suspected Progressive Familial Intrahepatic Cholestasis in Fetal Cases10039 Samonakis Dimitrios N. Treatment of Portal Vein Thrombosis in Cirrhosis: A Multicenter Real Life Study10650 Sa-nguanmoo Pattaratida Accessing HAV Antibody in the Thai Population10619 Sapmaz Ferdane Which is More Important for Development of Endothelial Dysfunction: Steatosis or Fibrosis?10110 Sargsyants Narina Succses in Difficult-to-Treat Patient with HCV-Associated Glomerul Onephritis10077 Sarker Md.Jahangir Alam Variant of Ascitic Fluid Bacterial Infections in Patients of Liver Cirrhosis10414 Sarwar Shahid Hepatorenal Syndrome: Response to Terlipressin and Albumin and Its Determinants11127 Sasaki Kengo Successful Living Domino Liver Transplantation Using Liver from A Maple Syrup Urine Disease Patient10847 Sasaki Reina HBV blocks MG132-Induced Apoptosis in Human Hepatic Stellate Cells10684 Sato Ken Therapy with Daclatasvir and Asunaprevir for Dialysis Patients with Hepatitis C: Case Reports 11190 Sato Koki The Risk Factors for Percutaneous Radiofrequency Ablation under Monitored Anesthesia Care10353 Sato Masanori Abnormal Iron Metabolism in Patients with Chronic Hepatitis C10622 Sato Masaya ADOPT-LC Score: A Novel Score for In-Hospital Mortality of Surgical Procedure in Cirrhotic Patients 10352 Sato Mitsuaki Deep Sequencing of Variants Resistant to Protease Inhibitor Therapy in HCV-1b Hepatitis10787 Sato Shinpei Hepatic Arterial Infusion Chemotherapy for Sorafenib Failure on Advanced HCC10017 Sato Takahiro Treatments of Bleeding Portal Hypertensive Duodenopathy10835 Sato Takahisa 38 Cases of Brain Metastases from Hepatocellular Carcinoma10251 Sato Yasunori Enhanced VASH1 Expression in Splenic Sinus Lining Cells Relates to Splenomegaly in IPH10508 Sawada Shintaro Preventive Effect of Geraniol on Hepatocarcinogenesis in Diethylnitrosamine-Induced Rats10579 Schwarzinger Michael Prognosis of Patients with Chronic Hepatitis B and Chronic Kidney Disease: A 6-Year Cohort Study10079 Sekiguchi Tomohiro Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in PBC10147 Sekimoto Tadashi Significant Relationship between Liver Stiffness and Waveform Patterns in the Hepatic Vein10148 Sekimoto Tadashi Prediction of the Response to Branched-Chain Amino Acid Medication by Liver Stiffness in Cirrhosis10455 Seko Yuya Progression and HCC in Japanese Patients with NAFLD10520 Sen Ilker An Engrossing Case of Delta Hepatitis10522 sen Ilker Exophytic and Pedinculeted Hemangioma of Liver:A Rare Entity10880 Seo Hye-Young Protective Effect of Clusterin on Hepatic Fibrosis10488 Sepulveda-Villegas Maricruz Use of Biochemical and Metabolic Markers for the Detection of Nonalcoholic Steatohepatitis (NASH)10388 Seto Wai Kay Walter Determinants for Persistent Fibrosis during Nucleoside Analogue Therapy in Chronic Hepatitis B10642 Setoyama Hiroko Reduced Human Serum Albumin is A Useful Biomarker of Progression in Chronic Liver Disease10761 Seyama Yasuji Simulation and Navigation Using A 3D Printed Liver Model in Laparoscopic Liver Surgery10588 Sezak Nurbanu Acute Hepatitis C Infection in Human Immunodeficiency Virus (HIV) Infected Case10070 Sezgin Orhan High Prevalence of Type 1 Gaucher Disease in Idiopathic Hepatosplenomegaly and/or Thrombocytopenia 20156 Shah Kaivan Is Rapid Virological Response (RVR) Significant in the Present Era in the Treatment of Hepatitis C 10725 Shah Samir Sofosbuvir plus Ribavirin in the Treatment of Chronic HCV Infection in India 10914 Shahera Umme IP-10, p53 and Foxp3 Expression in Hepatitis B Patients with Cirrhosis and Hepatocellular Carcinoma.11219 Shao Qing Cost-Effectiveness of Neutrino Regimen for CHC GT1b in China- A Real Life Study10082 Sharma Dilip Prevalence of Vitamin D Deficiency in Patients with Chronic Viral Hepatitis: A Nepalese Study11221 Shasthry Varsha BIA is in Proximate Agreement with CT Based Assessment of Sarcopenia in ALD Patients11301 Sheen I.Shyan Virological Breakthrough and Hepatic Toxicity in the Treatment with Daclatasvir plus Asunaprevir11233 Sheikh Nadeem Impact of Acute Fe & Cu Administration on Hematology and Biochemistry in Rattus Norvegicus

20081 Sheikh Nadeem Tacrolimus Induced Nephrotoxicity and Pulmonarytoxicity in Wistar Rats20083 Sheikh Nadeem Histopathological Alterations in Nervous, Cardiac and Pulmonary Tissues Induced by Thioacetamide20151 Shen Liping Analysis for 12 Strains of Whole Sequence of HBV C/D Recombinant of People in Tibet, China10986 Shen Tao Non-Neutralizing Epitopes Induce Robust ADCC Mediated by CD56+ NK Cells in Chronic HCV Infection

10919 Shen Ting The Changes in the Balance of Treg and Th17 after Entecavir Therapy10328 Shi Hong Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive CHB Patients with High HBV DNA10710 Shi Hongbo Protective Effect of Ganshuang Granules on Liver Cirrhosis by Suppressing Regulatory T Cells11012 Shi Lei HIV and HCV Cooperatively Promote Hepatic Fibrogenesis through Epimorphin Mediated Via FAK-ERK


Submission No. Last Name First Name Title of Abstract11337 Shi Ming Human Mesenchymal Stem Cell Therapy is Feasible for Liver Cirrhosis Associated with HBV Infection10767 Shi Xiao F. In Vivo Expression of TIMP-1/2 siRNA Promotes Apoptosis of HSC and Smad Protein Expression in Liver11271 Shi Xiao F. Inhibition of TGF-Beta and TIMP1/2 by siRNA Showed A Different Prevention of Hepatic Fibrosis11295 Shi Xin-xing Clinical Analysis of AKI in Patients with HBV-Related ACLF11039 Shiba Shunsuke Clinical Characteristics at the Time of Start of Diuretics for Ascites Predict Their Survival10045 Shibata Soichiro LSPS Identifies Esophageal Varices in Chronic Liver Disease10733 Shibuki Taro Evaluation of Factors Associated with Relapse of Type 1 AIH Patients.10820 Shigefuku Ryuta Hepatic Hemodynamics and Liver Function before and after Endoscopic Injection Sclerotherapy 11352 Shigeta Takanobu Hepatocyte Transplantation Using Living Donor Reduced Grafts11191 Shiha Gamal Fib5:A Novel Test Differentiating between Non-significant and Significant Fibrosis in CHC Patients 11196 Shiha Gamal Transient Elastography is not Useful in the Diagnosis of Schistosomal Hepatic Peri-Portal Fibrosis 20142 Shiina Shuichiro International Radiofrequency Ablation (RFA) Training Program11141 Shiina Shuichiro Juntendo University Radiofrequency Ablation (RFA) Training Program10130 Shikano Toshio Successful Laparoscopic Deroofing for Liver Cysts: Our Technique and Outcome11037 Shimizu Ryo Efficacy and Safety of Dual Oral Therapy with DCV and ASV after Curative RFA of HCV-Related HCC11046 Shimizu Ryo Radiofrequency Ablation by New Adjustable Electrode: Initial Experience11049 Shimizu Ryo Radiofrequency Ablation in Very Elderly Patients (85 years old or older) with Liver Tumors10959 Shimozuma Yuu Predictive Factors for Therapeutic Effects of Tolvaptan to Patients with Refractory Ascites10764 Shinkai Noboru WFA+- Mac-2 Binding Protein is A Predicting Biomarker for HCC in Hepatitis B Patients10344 Shirakami Yohei Preventive Effects of Pentoxifylline on Liver Tumorigenesis in A NASH-Related Liver Cancer Model11001 Shiraki Katsuya Daclatasvir and Asunaprevir for Chronic Genotype 1 Hepatitis C Virus Infection in Japan11024 Shrestha Ananta Asymptomatic Hepatitis E Viremia in Bloods Donors in Nepal11218 Shubham Smriti Compromised SDF1 Production by Liver Stromal Cells Suppress Hepatocyte Self Replication in ACLF.10567 Siburian Marlinang D. Lamivudine Resistance Mutations in Indonesian Chronic Hepatitis B Patients10671 Singh Jatinderpal Sleep Disturbances in Patients of Liver Cirrhosis with Minimal Hepatic Encephalopathy20145 Singh Shivaram P. Socioeconomic Impact of Alcohol in Patients with Alcoholic Liver Disease [ALD] in Eastern India.10930 Singh Tajinder Effect of Antiviral Therapy on Liver Stiffness in Patients of Chronic Hepatitis C10204 Siramolpiwat Sith Clinical and Histologic Features of Azathioprine-Induced Hepatotoxicity10531 Sirin Goktug Is There Any Impact of Thyroid Dysfunction on EVR in Patients with Acute HCV Infection?20009 Sobhonslidsuk Abhasnee The Incidence, Outcomes and Cost of Drug-Induced Liver Injury from A National Database in Thailand20010 Sobhonslidsuk Abhasnee Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Hepatitis B10759 Sofue Keitaro Stability of Liver Proton Density Fat Fraction and Changes in R2* Induced by Gd-EOB-DTPA10549 Sohn Kyoung Min Relation of Risk Factors between Metabolic Syndrome and Nafld in Apparently Healthy Young Adults10699 Sohn Kyoung Min Adipolysis Efficacy of Aged Black Garlic Extract in 3T3-L1 Adipocytes10804 Somani Vaibhav S. Role of Von Willebrand Factor Levels in Predicting Severity of Cirrhosis11056 Somani Vaibhav S. Comparing the TEG with Conventional Coagulation Tests in Cirrhotics Undergoing Invasive Procedures. 10994 Somi Mohammad Hossein Upper Gastrointestinal Endoscopic Findings in More Than 8500 Patients10557 Son Byoung Kwan Clinical Features and Antibiotic Sensitivity to Causative Microorganisms of Pyogenic Liver Abscess20055 Son Chang Gue Experimental and Clinical Studies for Development of Anti-hepatofibrotic Herbal Drug, CGX10749 Sonavane Amey D. Hepatocellular Carcinoma in Autoimmune Hepatitis : the Western India Experience11298 Song Haiyan New Effect and Mechanism of Protopanaxadiol in Improving Nonalcoholic Fatty Liver Disease10272 Song Il Han Clinical Implication of Portal Hypertensive Colopathy Accompanied by Cirrhotic Patients10630 Song Jeong-Yeop Is There A Link between Autoimmune Hepatitis and Bronchial Asthma and Irritable Bowel Syndrome?10043 Srisuk Tharatip Pancreaticoduodenectomy in A Huge Pancreatic Neuroendocrine Carcinoma of Infancy, Case Report20109 Srisuk Tharatip Surgical Outcome of Hepatocellular Carcinoma with Intraatrial Thrombus in Child B Cirrhotic Patient10484 Stelma Femke Treatment with Anti-MiRNA122 RG-101 Results in Decreased IP-10 in Patients with Chronic Hepatitis C10486 Stelma Femke Human Liver CD8+ T Cells Have A Tissue Resident Phenotype and Differ from Blood CD8+ T Cells10573 Su Tung-Hung The Activation of SH2 Domain-Containing Phosphatase-1 by SC-43 Ameliorates Hepatic Fibrosis11320 Subhan Amna Hepatitis E and ACLF: Predictors of Mortality in Asia Pacific Region Based on the AARC Data11283 Subramaniam V. Nathan Identification of A SNP in BMP6 Implicated in Iron Accumulation in 3 Asian Patients10294 Suetsugu Atsushi Change in Serum Levels of M2BPGi in Patients with HCV during the Treatment of Peg-IFN and RBV10214 Sugawara Kayoko Long-Term Outcome of Cirrhotic Patients with Bleeding Esophageal and Gastric Varices10483 Sugihara Takaaki Transient Elastography is Useful for Detecting High-Risk Patients of Liver Cancer10529 Sugimoto Takafumi Prophylaxis for Esophageal Varices Can Improves the QOL in Patients with PVTT10428 Sugiyama Akiko Periostin Promotes Liver Fibrosis by Activating Hepatic Stellate Cell Via Interacting Integrins11198 Sugiyama Harutoshi Primary Sclerosing Cholangitis Complicated with Cholangiocarcinoma10988 Sugiyama Ryuichi Amino Acid Substitutions in ISDR of HCV-NS5A Affect Infectious Virus Production and ISG Induction10587 Suh Sang Jun What Predicts Short Term Mortality in Patient with Variceal Bleeding?10100 Suhuyanly Nella Tuberculostatic Hepatotoxicity : Focused on NAT2 Enzyme Status and Polymorphism of CYP 2E110836 Sulaiman Andri S. Factors That Predict Pretreatment and on-Treatment SVR in CHC C Patients Treated with Dual Therapy11378 Sun Jian Baseline Vitamin D Level Predict Virologic Response in Hepatitis B Patients Treated with Telbivudine11122 Sun Yameng Reversion of HBV-Related Liver Fibrosis/Cirrhosis Starts from Septal Area Assessed by SHG Images11161 Sun Yameng Neglected Significant Fibrosis in Young HBV Patients: Evidence from China Registry of Hepatitis B11144 Sun Zhenhua Characterization of Circulating and Intrahepatic NK, NKT, CD4+ and CD8+ T Cells in HBV-Related HCC11112 Suzuki Eiichiro Efficacy and Safety of Sorafenib in Patients with Non-B, Non-C Hepatocellular Carcinoma in Japan11009 Suzuki Junya Analyzing RNA Exosome Mediated HBV-RNA Degradation Mechanism10891 Suzuki Yoshihiro Daclatasvir plus Asunaprevir for Hepatitis C Infected Patients in Shonai Area Yamagata Prefecture10467 Suzuki Yuichiro PreS Mutations are Correlated with the Progression of Liver Diseases and HBsAg/HBcrAg Productions10611 Swallow Elyse Indirect Comparison of Daclatasvir+Asunaprevir vs Sofosbuvir/Ledipasvir for HCV in Japanese Patients10284 Tabak Fehmi Epidemiology of HBV Subgenotypes D10530 Taguba Aubrey Q. Vitamin D Deficiency in Chronic Liver Disease Patients of the Philippine General Hospital10732 Taida Takashi The Clinical Difference of HBeAb-Positive Inactive Carrier among Medical Facilities in Japan10965 Taida Takashi The Prognosis of Hepatitis B Inactive Carrier in Japan: A Multicenter Prospective Study10032 Tajiri Kazuto The Impact of Neutrophil/Lymphocyte Ratio for the Recurrence of HCC after RFA10822 Tak Won-Young Comparison of Asians vs. Non-Asians Treated with TDF Plus Peginterferon (PEG)10719 Takaguchi Koichi Effect of Sofosbuvir and Ribavirin Treatment in HCV Genotype 2 Japanese Patients11061 Takahashi Koji Tenofovir Treatment for A Japanese Female with Chronic Hepatitis B and Pregnancy10223 Takaki Akinobu B Cell and Lineage Negative Cell Chimerism Induce Bad Outcome in Post Transplantation Hepatitis C 10823 Takaki Shintaro Daclatasvir and Asunaprevir Improve the Baseleine Parameters in Chronic Hepatitis C Patients10117 Takakusagi Satoshi Effiicacy and Safety of Daclatasvir and Asunaprevir for Patients Infected with HCV Genotype 111005 Takamura Masaaki Value of VTTQ Measurements for the Risk Assessment of HCC Development in Viral Hepatitis Patients20116 Takano Tomoko Natural History of Children with Chronic Hepatitis B: the Observational Multi-Center Study in Japan10641 Takashi Niizeki Efficacy of Hepatic Arterial Chemotherapy of CDDP Suspension in Lipiodol and 5-FU for Advanced HCC10895 Takayama Koji Controlled Attenuation Parameters is Efficient in the Quantification of Hepatic Steatosis11064 Takayama Koji Telaprevir-Based Triple Therapy will be Beneficial for Patients of High Alpha-Fetoprotein Level20087 Takechi Hitomi Late-Onset Diaphragmatic Hernia after Radiofrequency Ablation of Hepatocellular Carcinoma

Submission No. Last Name First Name Title of Abstract11133 Takeda Haruhiko Ultra-Deep Sequencing for Detection of Low Abundant Drug-Resistant HCV in Patients Receiving DAAs11023 Takemura Shigekazu S-Allyl Cysteine Improves Fatty Liver Disease and Diabetes in Otsuka Long-Evans Tokushima Fatty rats10047 Takuma Yoshitaka Diagnostic Accuracy of Spleen Stiffness for the Portal Hypertension in Patients with Liver Cirrhosis10109 Tamori Akihiro Randomized Trial of Two Types of Peg-IFN with Simeprevir Combined Therapy for Patients with HCV 1b10753 Tanaka Hironori Comparison of the Latest Fusion Technology11058 Tanaka Junko Disease Burden of Chronic Hepatitis C Virus (HCV) Infection in Japan10833 Tanaka Masahiro Routine Gd-EOB-MRI is Recommended for the Preoperative Evaluation of Colorectal Liver Metastases10258 Tanaka Yasuo Sharpin Cooperates with Wnt Pathway to Transactivate Versican Expression and Promote HCC Invasion10193 Tanaka Yoshiaki SPIO-Enhanced MRI is Useful in Predicting Hypervasculalization of Hypointense Hypovascular Nodules10305 Tanchanco Camille Ariadne C. Role of Vit K in Prevention of Post Sphincterotomy Bleeding in Patients with Normal Prothrombin Time11132 Tang Chun ASPH Disrupts Mitochondrial DNA Stability and Mitochondrial Function in Hepatocellular Carcinoma11347 Tang Libo Decreased Titers of IgG-AMA are Associated with Biochemical Response to UDCA Treatment in PBC10860 Tang Lydia Comparative Efficacy of Generic Sofosbuvir Versus SOVALDI with Ribavirin for Hepatitis C10958 Tanzem Bushra Sequencing HBV Polymerase & Surface Genes Circulating in A Bangladeshi Cohort11354 Tao Shiqi Investigation into the High Prevalence of HCV Infection in A Rural Village in Southwest China10041 Tarasova Olga HBsAg Quantity for Monitoring of Hepatitis B Virus Infection in Inactive Carriers10487 Tatagawa Kiichi Multi-Planar or Curved-Planar Reconstruction in the Detailed CT Analysis of Cholelithiasis10493 Tateyama Masakuni A Randomized Study of the PegIFN-Based Regimen with Simeprevir for Chronic Hepatitis C11368 Tavartkiladze Alexandre The Role of Cellular Immunity in the Pathogenesis and Treatment of Patients with Liver Cancer11369 Tavartkiladze Alexandre Clinical Characteristics of Glycine and Taurine Exchange in Patients with Liver Cancer20163 Tawada Akinobu AFP Level is A Useful Predictor of HCC in Chronic Hepatitis B Patients Treated with NUCs10617 Tejima Kazuaki Usefulness of IgA Anti-HEV Antibody for Diagnosis of Acute HEV Infection10888 Teng Wei Response at First Chemoembolization Plays A Favorable Outcome in Hepatocellular Carcinoma10199 Tey Sze Keong Nuclear Met Regulates Liver Cancer Metastasis Via NF-κB/MMP2 Pathway10235 Tey Tze-Tong Hemodynamic Response to Propranolol for Treatment of Portal Hypertension in A Center in Singapore10166 Thai Ky Doan Long-Term Survival Results of HCC Patients after Drug-Eluting Beads TACE10937 Thandassery Ragesh B. Simple Non-Invasive Scores in Predicting Significant Liver Related Events in Chronic Hepatitis C11235 Thandassery Ragesh B. Ferrokinetics, Calcium, Vitamin D and Red Blood Cell Indices in Treatment of Chronic Hepatitis C10943 Tharwa El-Sayed S. Correlation Between Character of Portal Blood Flow and Post-TIPS Incidence of Hepatic Encephalopathy10295 Thong Vo Duy Prevalence of TA Repeat, IL28B, IFNL4 and Correlation with Treatment Outcome of HCV Infection10327 Thuy Le T.T. Protective Role of Cytoglobin in Liver Inflammation and Fibrogenesis in Mouse Steatohepatitis Model10325 Thuy Tuong Thi Van Cytoglobin Deficiency Enhances Liver Injury and Fibrogenesis during Cholestasis in Mice20113 Tingting Feng Diagnosis Value and Correlation with Immune Regulatory Factors of MSP in ACLF Patients11241 Tkachenko Petr Prednisolone plus S-Adenosil-L-Methionine in Severe Alcoholic Hepatitis10783 Tobari Maki Clinical Significance of the Serum IgG3 in Primary Biliary Cirrhosis 10653 Togashi Junichi Living Donor Liver Transplantation for HIV/HCV Coinfected Recipients with Hemophilia10238 Tokoro Masanori The Impact of Alpha Fetoprotein (AFP) Level during IFN Free Treatment for Hepatitis C10462 Tokumoto Yoshio Efficacy and Safety of Asunaprevir and Daclatasvir Therapy for Chronic Hepatitis C Patients10990 Tokunaga Takayuki Clinical Evaluation of 40 Cases with Treated Hepatic Cysts11088 Tolmane Ieva Relationship between Patient Lifestyle and Development of Fatty Liver Disease10723 Tomeno Wataru Major Depressive Disorder Adversely Affect Treatment Outcomes of Non-Alcoholic Fatty Liver Disease10011 Tomimaru Yoshito Aspartate-Β-Hydroxylase Generates Epitope-Specific T Cell Responses in Hepatocellular Carcinoma11068 Tomiyama Yasuyuki Comparative Analysis of Miriplatin and Doxorubicin in TACE for HCC Using Propensity Score Matching10016 Tomizawa Minoru Autoimmune Hepatitis Patients Positive for Anti-Mitochondrial M2 Antibody10255 Tong Guangdong Effect of Switching to or Adding on Ltd on Renal Function in CHB with Suboptimal Response to ADV10797 Torres-Valadez Rafael Early Diagnosis and Biological Markers in Advanced Liver Damage of Different Etiologies11277 Tosun Selma The Paths to Diagnosis in HBsAg Positive Individuals11284 Tosun Selma Testing of Kidney Transplantation Candidates for HBV Infection and the Importance of Monitoring 11287 Tosun Selma Evaluation of HBV Infection Status in Family Members of HBsAg-Positive Individuals 11318 Tosun Selma Are Hepatitis Patients Hiding Their Disease ?11325 Tosun Selma Evaluation of Needle Stick and Sharp Injuries among Healthcare Personel11342 Tosun Selma Evaluating the HAV Seroprevalence of Health Care Workers 10667 Toyoda Hidenori GIFT-I: ALT Changes with Ombitasvir/Paritaprevir/Ritonavir and Concomitant Use of Hepatoprotectives10115 Triantos Christos Natural History of Grade 1 Ascites in Patients with Liver Cirrhosis10528 Tsai Wei-Lun Metformin Activates Type I Interferon Signaling against HCV Via Activation of AMPK10358 Tsuchiya Atsunori An EpCAM/NCAM Expressing HCC in Which Progenitor Marker Positive Cells are Important for Metastasis10984 Tsuchiya Takahiro Duodenal Jejunal Bypass Improves Non-Alcoholic Steatohepatitis in Rats10546 Tsuda Yasuhiro Antiviral Effects of Daclatasvir and Asunaprevir Therapy on the Liver Function in Hepatitis C10634 Tsuge Masataka Nucleotide Analogues Improve Interferon Responsiveness in HBV-Infected Human Hepatocytes11035 Tsuyuguchi Toshio Role of Peroral Cholangioscopy for Diagnosis of Intraductal Papillary Neoplasms of the Bile Duct11247 Tu Bo Curative Effect on Foscavir Treatment for Patients Infected by HIV Merger EB Virus11311 Tulek Necla Chronic Hepatitis B Treatment; Real Life Data, an Experience of a Centre 11327 Tulek Necla Seroprevalence of Hepatitis A and Hepatitis B 11262 Tuna Nazan the Relation of Serum Vitamin A Level with Chronic Hepatitis C 10871 Turkay Cansel Role of Paraoxonase-1, Caspase Cleaved Cytokeratin 18 and Pentraxin-3 Levels in Nafld 10874 Turkay Cansel Echocardiographic Findings in Patients with Non-Alcoholic Fatty Liver Disease10583 Turker Nesrin Acute Hepatitis C Infection: A Case Report11314 Tuzcuoglu Isil HBsAg Loss in Patients with Chronic HBV Treated with Entecavir: A Retrospective Case Series10379 Tyagi Satyendra K. Impact of HCV Treatment on Impoverishment in Western Uttar Pradesh, India10813 Uchida Takuro CTL Mediated Acute Liver Failure and Rescue by CTLA4Ig in Human Hepatocyte Transplanted TKNOG Mice

10582 Uchikoshi Manabu Evaluation of B Cell Activating Factor during the Interferon Based or Free Therapy in CH-C Patients10410 Udomsinprasert Wanvisa Lower Mitochondrial DNA Copy Number is Associated with Telomere Length in Biliary Atresia 11004 Umehara Matsuki Non-Invasive Assessment of Hepatic Steatosis in Patients with Anorexia Nervosa Using Elastography10297 Umetsu Shuichiro Clinical Course and Outcome of PSC/AIH Overlap Symdrome in Children10766 Ura Kazuya Rapid Decrease of the Non-Invasive Serum Liver Fibrosis Marker WFA+-M2BP by IFN-Free Therapy

11238 Ura Kazuya Age and Female are the Risk Factors for HCC Even in Chronic Hepatitis C Patients with SVR10742 Urata Yukitomo Cessation of Pre-Emptive Therapy for Patients with Rheumatic Disease with Previously Resolved HBV10021 Uyanikoglu Ahmet HBsAg (+) Patients Distribution, Clinical and Demographic Characteristics in Turkey Sanliurfa Region10161 Uygun Ahmet Nonalcoholic Fatty Liver Disease is An Independent Risk Factor for Atherosclerosis in Young Adult11091 V Andrew Antiviral Effect of Therapy with REP 2139-Ca and Nucleos(t)ide Analogues against HBV in Vivo11090 Vaillant Andrew HBsAg and HDV RNA Reduction with REP 2139-Ca and Peg-INF Alpha 2a in Chronic HBV/HDV Infection11111 Valaydon Zina S. Chronic Hepatitis B in Australia: High Prevalence of Variants Associated with Disease Progression20052 Valmori Danila Cancer Vaccine Development for Hepatocellular Carcinoma - HEPAVAC10477 Van der Ree Meike H. A Single Dose of RG-101 Results in Undetectable HCV-RNA Levels in Chronic Hepatitis C Patients10478 Van der Ree Meike H. Plasma Microrna Levels are Associated with Therapy Response in Chronic Hepatitis B Patients10218 Varakanahalli Shivakumar Gastric Varices in Cirrhosis vs EHPVO and Response to Endoscopic N-Butyl-2-Cyanoacrylate Injection


Submission No. Last Name First Name Title of Abstract20056 Vilaichone Ratha-korn Clinical Characteristics and Treatment Outcomes of HCC Due to CHB and CHC Infections in Thailand10000 Vinken Mathieu Inhibition of Pannexin1 Channels Alleviates Acetaminophen-Induced Hepatotoxicity10977 Vutien Philip Treatment Rates of Chronic Hepatitis C (CHC): A Meta-Analysis of 12 Studies and 307,031 Patients11286 Vyas Tanmay S. Effect of Metformin on Disease Progression of NASH-Cirrhosis with Diabetes/Insulin Resistance10449 Wada Nozomu Efficacy of Combination Therapy of Daclatasvir and Asunaprevir for HCV Genotype 110518 Wada Nozomu Prognostic Factors of the Patients with TACE -Refractory Hepatocellular Carcinoma11050 Wakamatsu Toru Glisson's Capsule Injury after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma11043 Wake Taijiro Hepatic Infarction after Percutaneous Radiofrequency Ablation for Liver Tumors10075 Wakui Noritaka Utility of Heartbeat-Induced Strain Elastography (S-Map) in Staging Fibrosis in NASH10162 Wallace Jack Multiple Failures: Addressing the Barriers to Hepatitis B Treatment in China 11200 Wang Cheng Hepatitis B Reactivation in CHC Chinese Treated with Pan-Oral DAAs-A Prospective Study11340 Wang Gui-Qiang Selected Cytokines Predicting Liver Histology in CHB Patients with Normal to Mildly Elevated ALT11150 Wang Guiyang Regulatory B Cells Increase in Immune Reactive Phase of Chronic Hepatitis B Virus Infection10544 Wang Hongwu An Essential Role of Regulatory T Cells: Prevention of Alcohol-Induced Hepatic Steatosis in Mice11123 Wang Huan Red Cell Distribution Width is Related to Histologic Severity of Primary Biliary Cirrhosis20152 Wang Kai Increased A20 mRNA Level in PBMCs is Associated with Immune Phases of Chronic Hepatitis B10563 Wang Li HBsAg Seroclearance after Treatment-Induced HBeAg Seroclearance in Chronic Hepatitis B Patients11346 Wang Li Long-Term Outcomes after Nucleos(t)ide Analogue Withdrawal in Patients with HBeAg-Positive CHB11155 Wang Lin Prevalence of HDV in Chinese Active CHB is Low, with Similar Clinical Profiles as Non-HDV Patients10421 Wang Mingjie Characterization of Gene Expression Profile in HBV-related Liver Fibrosis Patients11107 Wang Ping Hepatic Stem/Progenitor Cells are Sox9 and AFP Double Positive in Human Cirrhosis Liver10974 Wang Shen-Yung Cooling Via A Gallbladder Drainage Tube during Radiofrequency Ablation Reduces Gallbladder Injuries10165 Wang Tong-Hong LncRNA CPS1-IT1 Suppresses Hepatocellular Carcinoma Metastasis by Regulating HIF-1Α Activity11265 Wang Tsang-En ADI-PEG-20 as Salvage Therapy in A Patient with Advanced Hepatocellular Carcinoma10326 Wang Xiaoxiao Inhibition of HBsAg on HCV Replication by Increasing NKG2D Expression on NK Cells in CHB Patients10865 Wang Yin Chen The Impact of on-Treatment ALT Flares on Response to Peginterferon Alpha-2a in CHB Patients11313 Wang Yujia Characterization of Crosslinked Porcine Extracellular Matrix as Scaffold for Thepatic Bioengineering11290 Wang Yuming Risk Factors for Liver Failure from Immunosuppressive Therapy-Induced Hepatitis B Virus 11002 Ward Tom Assessing the Economic Impact of New Direct-Acting Antivirals for Chronic Hepatitis C in Japan10654 Wasitthankasem Rujipat Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade; An Evidence-Based Study10869 Wasityastuti Widya Quasispecies of Antiviral-Resistant in Naive and Undertreated HBV Infected Patients in Indonesian 10461 Watanabe Takao Protein Kinase R Modulates DNA Methylation in Hepatocellular Carcinoma with HCV Infection10620 Watanabe Takehisa Lymphotoxin-Β Regulated by NF-κB is A Biomarker of Poor Prognosis in Hepatocellular Carcinoma.

11031 Wei Lai DCV + ASV in IFN (± RBV)-Ineligible/Intolerant Asian Patients with Chronic HCV Genotype-1b Infection

11063 Wei Lai Integrated Safety and Tolerability of DCV + ASV in Patients with Chronic HCV Genotype 1b Infection11291 Wen Xiaoyu A Case of Severe Hemophagocytic Syndrome Secondary to Chronic Active EBV Infection.10505 Wen Ya Serum Level of microRNA in the Patients with ACLF Related HBV Infection11151 Win Khin M. Treatment Chronic Hepatitis C Myanmar Patients with Sofosbuvir, Pegylated Interferon and Ribavirin.10957 Win Nan Nwe Analysis of Hepatitis C Virus Genotypes from Previously Discrepant Diagnostic Results10961 Wong Danny Hepatitis B Virus Core-Related Antigen as A Surrogate Marker for Covalently Closed Circular DNA10065 Wong Grace SLC10A1 Variant is Associated Liver Fibrosis in Patients with Chronic Hepatitis B11156 Wong Kang-Hsuan Cytokine Levels Associated with Risk for Hepatocellular Carcinoma Among Patients with HCV Infection10470 Wong Siow-Yi Clinical Outcomes of Autoimmune Hepatitis in North-East Scotland10122 Wong Yu Jun Baseline Liver Stiffness Measurement Can Predict Liver Related Events in Chronic Liver Disease10346 Wong Yu Jun Management of Biliary Complications Post Liver Transplant in Singapore10143 Woynarowski Marek Long Term Follow up of AIH Children after 6-12 Months Course of Budesonide and Azathioprine Therapy10142 Wozniak Malgorzata Autoimmune Hepatitis (AIH) in Patients Transferred from Pediatric to Adult Hepatology Care11162 Wu Chao Red Cell Distribution Width to Albumin Ratio, A Novel Index of the Severity of Chronic HBV Infection10364 Wu Da-Xian Combined HRM with Bayes Discriminant Method: A Novel HCV Genotyping Method10402 Wu Di TLR2+ Monocyte and PD-1+CD8+T Cell Correlate with Virologic Breakthrough after Switching to PegIFN20065 Wu Dongbo STAT1 Mediates Injury of HBV-Infected Cell Through Effect of TRAIL on IFN and Caspase Signal Pathway10571 Wu Liang Durability of Telbivudine Efficacy off-Treatment in Chronic Hepatitis B Patients11217 Wu Qinmei Quantitative Fibrosis Parameters Highly Predict Esophageal Varices of Primary Biliary Cirrhosis11373 Wu Quanxin Change Pattern of HBV B/C in Vertical Transmission10033 Wu Szu-Yuan Hepatocellular Carcinoma Received Palliative Treatments with Statin11179 Wu Xiaoning Regression of HBV-Induced Liver Cirrhosis: A Preliminary Data of A Randomized, Prospective Study11184 Wu Xiaoning Clinical Effects of Entecavir vs Lamivudine plus Adefovir on HBV-Related Compensated Cirrhosis10960 Wu XiaoPing Role of Th17 and Treg cells in the Progression of Grave Hepatitis B Infection 10201 Wuestefeld Torsten A Dynamic Relationship between Cellular Senescence and Liver Regeneration.10394 Xi Dong Down-Regulated miR-181c was Related with HBV Associated Acute-on-Chronic Liver Failure by TNFalpha20073 Xie Jing Pre-Clinical Studies of Animal Irreversible Electroporation Treatment of Liver Cancer20071 Xie Qing 5-Year Telbivudine Optimized Treatment for CHB Shows Sustained Viral Suppression and Low Resistance11178 Xie Xiaomeng Lower Class 1 ADH and ALDH2 Expression Predict Poorer Outcome in Male Patients with Liver Cancer11120 Xin Zhiying Expression of SALL4 in Hepatocellular Carcinoma and Its Clinical Significance10086 Xu Wenxiong 48 Weeks Follow-up in CHB Patients after NAs Treatments Cessation10770 Xu Wenxiong 24 Weeks Follow-up in CHB Patients after NAs Treatments Discontinuation20086 Xu Wenxiong Immunologic Examinations in CHB Patients after NAs Treatments Cessation11345 Xu Xiangsheng Polyclonal B Cell Activation Induced by Tfh Correlated with Th17 Mediated Liver Damage in CHB11182 Xu Xijing A Case of Fanconi Syndrome Induced by TCM in A Chronic Drug Induced Liver Disease Patient11129 Xue Yuan Characterization of HBV Whole Genome by Ultra Deep Sequencing during Acute Infection of G145R Mutant10226 Yam Judy W. Nuclear Met-Derived Exosomes Promote HCC Metastasis and Formation of Lung Premetastatic Niche10155 Yamada Koki Predictors of Acute Liver Failure with Hepatic Coma and Its Relationships to Outcome. 10856 Yamada Norie HCV Reactivation and HCC Development after Achievement of HCV RNA Negative by Peg-IFN/Rbv Therapy

10513 Yamada Shinichiro High NEK2 Expression in Hepatocellular Carcinoma Patients after Hepatectomy11229 Yamada Tomoharu Intrahepatic Cholangiocarcinoma Arising in Patients with Hepatocellular Carcinoma11121 Yamada Yuuri the Combination Therapy of Daclatasvir and Asunaprevir for Chronic HCV Genotype 1b Infection.10315 Yamagiwa Satoshi Efficacy and Safety of SMV-Based Triple Therapy for Patients Aged 66 Years and Older with CHC10395 Yamagiwa Yoko Strategies to Improve Utility of Chronic Hepatitis B Therapy Based on Questionnaire Survey in Japan10602 Yamamoto Chikako Sero-Epidemiological Study of Hepatitis Viral Infections among 2,105 Employees in Hiroshima, Japan10370 Yamamoto Naoki L-Carnitine Prevents Liver Fibrosis and Preneoplastic Lesions in Rat Model Induced by CDAA and DEN10537 Yamamoto Naoki The New Drug,Sodium-Glucose Cotransporter-2(SGLT2)Inhibitor Prevents Liver Fibrosis and Cancer 10188 Yamamoto Ryuichi Endoscopic Management of Occuluded Biliary Stents: A Single Center Study10343 Yamamoto Yasunori Upregulated Intestinal Absorption of Dietary Saturated Fatty Acids in Non-Alcoholic Steatohepatitis10127 Yamane Keiko Prognostic Analyses of Progressive Disease Patients with Advanced Hepatoma Treated with Sorafenib10270 Yamani laura Navika Quasispecies Variants of Surface HBV Detected by Ultra-Deep Sequencing in Indonesian Patients10800 Yamashiki Noriyo Indication of Liver Transplantation for Acute Liver Failure with Pancreatitis: Report of Two Cases


Submission No. Last Name First Name Title of Abstract11357 Yan Cunling Detection of HBV Surface Antigen Mutations in Patients with Chronic HBV by ELECSYS HBsAg II Assay10221 Yan Libo the Hepatitis B Virus (HBV) HBx Protein Activates RSK2 to Simultaneously Regulate HBV Replication10495 Yanagi Yusuke A New Strategy for Liver Tissue Fabrication and Transplantation.11232 Yang Aiting Dynamic Changes of HBsAg in HBV Patients: Genotype C had A Greater HBsAg Decline Than Genotype B11362 Yang Aiting Elastin Derived Peptide Facilitates Liver Fibrosis Regression Via Promoting aHSCs Reversion10762 Yang Hyun Korean Validation and Comparison of Prognostic Scores for Transarterial Chemoembolization10705 Yang Jong In Enteral Parasite Detection by Stool Exam, Abdominal US/CT, & Colonoscopy during Health Checkup10371 Yang Qifan Increased Expression of Mitochondrial Dynamics Protein Drp1 in Hepatocellular Carcinoma11187 Yang Ruifeng Trace Amount of HBsAg in Samples for Pre-Surgery Testing was Detected Using An Ultra-Sensitive Assay11197 Yang Ruifeng Performance Evaluation of the HISCL® HCV Serotyping Assay in Chinese Chronic Hepatitis C Patients10704 Yang Sien-Sing Statins Reduce Esophageal Variceal Rebleeding in Post-Endoscopic Variceal Ligation Patients11299 Yang Zhiyu the Effect of DAA Antiviral Therapy on Hepatitis C Virus-Related Thrombocytopenia: A Case Report11312 Yao Mingjie AFP Still is A Valuable Diagnostic and Prognosis Predicting Biomarker in HBV Infection-Related HCC10795 Yara Shoichiro Dysregulation of Hepatic 27-Hydroxycholesterol in Steatohepatitis Model Mice with Hyperglycemia10889 Yardimci Ahmet C. Are We Missing Out Some of Chronic Hepatitis B Patients Who Actually Needs Treatment?10859 Yasuda Satoshi Risk Factor for Development of HCC in Patients Who are Eradicated Hepatitis C Virus11044 Yasui Shin Factors Influencing Infectious Complications in Severe and Fulminant Hepatitis.10434 Yasunaka Tetsuya Laparoscopic Finding Can Predict the Progression in Patients with Primary Biliary Cirrhosis11109 Yavuz Fatma Serum Ischemia Modified Albumin Level in Chronic Hepatitis B and ITS Relation with Fibrosis 10972 Yee Christine CD147 in the Immune Response to Liver Injury in A Novel Conditional Knockout Mouse Model. 11370 Yeh Byung Il Inhibition Effect for the Growth of Hepatocellular Cell Line Fibroblast Growth Factor (FGF) 510242 Yeh Chau-Ting A Risk Score for Predicting Future Occurrence of Hepatocellular Carcinoma in Cirrhotic Patients10625 Yeh Chau-Ting Distinct Circulatory miRNA Profiles between Cirrhotic Patients Infected with Hepatitis B and C Virus11269 Yeh Chau-Ting TG-2349 3-day Monotherapy with Significant Antiviral Activity in Caucasian and Asian HCV Subjects20078 Yeh Matthew M. Hepatic Steatosis is Associated with Hepatocellular Carcinoma in Patients without Viral Hepatitis11149 Yeh Shiou-Hwei Hypoxia-Activated Cytotoxic Tirapazamine Kills HCC by Hepatic Artery Ligation in HBx Transgenic Mice10171 Yeh Trai-Ming Molecular Mechanism of Concanavalin A-Induced Autophagic Cell Death of Human Hepatoma Cells10061 Yew Kuo Chao Hepatocellular Carcinoma Tumour Ablation Procedures - Less is More ? 20137 Yi Nam-Joon The Fate of Recurred Hepatocellular Carcinoma after Curative Primary Liver Resection11104 Yildirim Beytullah Possible Role of Hepatitis B Virus in the Etiology of Cryptogenic Cirrhosis10626 Yildiz Orhan Sofosbuvir, PegIFN and Ribavirin for 12 Weeks in Treatment-Naive HCV Genotype 1b Patient10982 Yim Hyung Joon Endoscopic Variceal Obliteration vs BRTO as A Prophylactic Treatment for Gastric Varices11025 Yokokawa Hiroshi Vaccination Study of Cell Culture-Generated Hepatitis C Virus Particles in Non-Human Primate Model10802 Yokoyama Hiroshi Distribution of Hepatic Stellate Cells Which Express LRAT and/or CRBP-1 in NASH Patients11153 Yokoyama Masayuki Sofosbuvir plus Ribavirin for HCV Genotype 2a Reinfection after LDLT10407 Yoo Yang Jae Influence of HBV DNA on Recurrence of HCC after Surgical Resection and Role of Antiviral Therapy10808 Yoon Eileen L. Significant Factors for Mortality in Patients with Acute Decompensation of Chronic Liver Disease11115 Yoon Eileen L. Impact of Grade I ACLF on 1-Year Survival in Cirrhotic Patients with First Acute Decompensation10015 Yoshida Alfonso Syoei R. Profile of Patients Diagnosed with Fatty Liver Disease at Seamen's Hospital11164 Yoshida Chiharu Possible Gender Difference of NAFLD in Adolescence Evaluated by Elevated Liver Enzyme Levels10846 Yoshida Hideo Hepatic Ascites Treatment with Novel Diuretic - Vasopressin V2 Receptor Antagonist (Tolvaptan)10219 Yoshida Hiroshi Preoperative Liver Functional Volumetry Performed by 3D-99mTc-GSA Scintigraphy/Vascular Fused Images10347 Yoshida Katsunori Reversible pSmad3 Signaling between Tumor Suppression and Fibrocarcinogenesis in Chronic Hepatitis B10178 Yoshida Mariko Sorafenib Targets CD90+ Cancer Stem Cells and Controls Distant Metastasis10466 Yoshida Osamu Promotion of Liver Transplant Tolerance by Hepatic Plasmacytoid Dendritic Cells10852 Yoshida Yuichi Frequency and Severity of Liver Injury during Daclatasvir and Asunaprevir Dual Therapy for HCV10301 Yoshikawa Masato Elevated Preoperative Serum CEA Levels in Patients with HCC is Associated with Prognosis and EMT10412 Yoshizawa Kaname Incidence and Prevalence of Autoimmune Hepatitis in the Ueda Area, Japan10805 Yotsuyanagi Hiroshi High Prevalence of Comorbidities and Contraindicated Medications in CHC Patients in Japan11157 You Hong Dynamic Changes of Liver Stiffness to Define Reverse of HBV-Related Fibrosis after Antiviral Therapy10574 Young Shih-Hao Entecavir to Prevent HBV Reactivation by Chemotherapy for CHB Patients with Non-Hematological Cancer10736 Younossi Zobair M. Impact of Ledipasvir/Sofosbuvir on the Work Productivity of Chronic Hepatitis C Patients in Asia10876 Younossi Zobair M. Quality of Life of Japanese Patients with Chronic Hepatitis C Treated with Ledipasvir and Sofosbuvir10877 Younossi Zobair M. Higher Quality of Life Gains in Japanese Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir10902 Younossi Zobair M. Increased Cancer Rates in CHC Patients: An Analysis of the Cancer Registry in A Large U.S. HMO10904 Younossi Zobair M. Association of SVR and All-Cause Mortality Post INF-Based Therapy for CHC in A US Community Setting 10910 Younossi Zobair M. HCV Patients Treated with IFN-Free Regimens Experience Improvement of Patient-Reported Outcomes10912 Younossi Zobair M. Work Productivity Impairment in Asian Patients with Hepatitis C Treated with Different Regimens11034 Younossi Zobair M. High Therapeutic Efficiency of LDV/SOF in Asian Patients with CHC Genotype 1 Infection11113 Younossi Zobair M. the Value of Cure for Chronic Hepatitis C (CH–C) to the Society10892 Younossi Zobair M. Predictors of Adherence to Treatment of Chronic Hepatitis C (CHC)20107 Youssef Magdy M. Activity of Hepatic Stellate Cells in Chronic Hepatitis C Virus Infection11148 Yu Ge An ssDNA Aptamer Selectively Delivers Cytotoxic Drug to Hepatocellular Carcinoma Cells 10708 Yu Lei Copper Deficiency in Liver Disorders: Implications for Disease Mechanism and Clinical Management11251 Yu Ming-Lung Rapid Antiviral Response with TG-2349 plus PegIFN-RBV in Naive GT-1b Subject: An Interim Analysis10666 Yu Sulin MicroRNA-155 in Peripheral Blood Mononuclear Cells of Patients Infected with Hepatitis B Virus20051 Yu Xueping IL-9 and IL-10 but not Th9 Cells are Associated with survival of Patients with ACLF20115 Yu Xueping The Clinical Significance of Serum HBsAg/HBV DNA Ratio in Patients with Chronic HBV Infection11310 Yu Yiqi Sequential Combination of PegIFN in ETV-Experienced Patients and PegIFN in Treatment-Naive Patients10083 Yue Shi Macrophage &Beta-Catenin is Critical to Regulate Innate Immunity in Liver Inflammatory Injury11066 Yuen Man-Fung Effective Inhibition of cccDNA Derived mRNA/Viral Antigens and Tolerability with ARC-52010553 Yusuf Fauzi A Female with Massive Ascites: A Diagnostic Dilemma of Unknown Primary11180 Yusupbekov Abrorjon The Results of Treatment of Gastric Cancer with Liver Metastasizes11195 Yusupbekov Abrorjon Liver Function Correction in Pancreatic Cancer Patients with Obstructive Jaundice11201 Yusupbekov Abrorjon The Results of Chemoembolization and Endoarterial Chemotherapy in Primery Hepatic Carcinoma11323 Zaragoza-Organista R. Fernanda Fibrolamellar HCC Hepatectomy and Postoperative Acute Vena Cava Syndrome and Successful Thrombectomy

10422 Zeng Fan Neutrophil-Lymphocyte Ratio, An Artificial Liver Support System and Prognosis 11376 Zeng Qing-Lei Clinical Model for Predicting the Post-SVR of HCC in CHC Patients: A Case Control Study11377 Zeng Qing-Lei Sofosbuvir plus Daclatasvir with Ribavirin for 12 Weeks in Chinese Refractory Hepatitis C Patients 11177 Zeng Zhenzhen A Tumor Suppressor Role of microRNA-9 Via Targeting IGF2BP1 in Hepatocellular Carcinoma10066 Zhang Chi Cost-Effectiveness of Lamivudine plus Adefovir Combination Therapy in Chronic Hepatitis B Patients10024 Zhang Feng Influence of CYP2D6 and Β2-AR Gene Polymorphisms on Hemodynamic Response to Propranolol in Chinese

10750 Zhang Feng TWEAK Suppresses Activated Hepatic Stellate Cell Senescence in Vitro Via Regulating SIRT1 and p5311258 Zhang Haiying Prevalence and Clinical Correlates of Autoantibodies in Chinese Patients with Chronic Hepatitis C10303 Zhang Hang HBXIP Negatively Regulates Antiviral Response by Promoting Proteasomal Degradation of TBK110203 Zhang Li Changes of the Humoral Immune Response in CHB Patients with PEG-IFN Therapy


Submission No. Last Name First Name Title of Abstract10197 Zhang Miao the Expression of Circulating TFH Cells and CD19+B B Cells in CHC Patients with PEG-IFN Therapy10062 Zhang Min-Yue Network Meta-Analysis of Nucleotide Analogues for Preventing HBV Reactivation during Chemotherapy11116 Zhang Qi Incidence of Spontaneous Resistance Mutation in Untreated Chronic Hepatitis B Patients in China11175 Zhang Ruiyang CXCL2 Plays A Tumor Suppressing Role Through Recruiting N1 Neutrophils in Hepatocellular Carcinoma10476 Zhang Ruyi Analysis Th17/Treg Balance and Specific Transcription Factor(RORγt,Foxp3) in CHB Patients10481 Zhang Ruyi Analysis Th17/Treg Balance and Correlation with Liver Function,HBVDNA in CHB Patients10498 Zhang Xiao L. Epidemiological Characteristics on HIV Co-Infection with HBV and/or HCV11308 Zhang Yan-Qiong The Efficacy and Safety of Telbivudine or Tenofovir in Pregancy for Prevention of MTCT of HBV11356 Zhang Yan-qiong Horizontal Transmission of HBV after Successful MTCT Prevention: A Case Report11209 Zhang Yuexin Clinical Characteristics and Risk Factors of Portal Vein Thrombosis in Liver Cirrhosis11374 Zhao Jing Min Effect of Raft-Associated TLR7 Activation on Proliferation and Migration of Hepatocellular Carcinoma11365 Zhao Jingmin Serum PEDF as An Independent Biomarker in Non-Invasive Diagnosis of NASH11367 Zhao Jingmin ANGPTL6 Inhibites Hepatocarcinoma Metastasis by Promoting Wnt Pathway Through Macrophages10316 Zhao Juanjuan Antifibrotic Activity of NK Cells is Impaired by TGF-Β-Dependent Emperipolesis in Liver Cirrhosis20084 Zhao Qiyi Up-Regulation of Tumoral IDO is Driven by Monocytes and T Lymphocytes Collaboration11171 Zhao Yang J. Transcription Factor RFX5 is A Transcriptional Activator of TPP1 Gene in Hepatocellular Carcinoma20134 Zhao Hong Des-&gamma-Carboxy Prothrombin is A Complementary Biomarker in Diagnosing Hepatocellular Carcinoma

20135 Zhao Hong Unbalanced Distribution of Medical Resources for Liver Diseases in Mainland of China20136 Zhao Hong Clinical Characteristics of Liver Cirrhosis Over 22 Years in China10793 Zhong Shan CD36 Deficiency Aggravates the Development of NASH Via Up-Regulating MCP-1 Expression in Hepatocytes

11181 Zhong Yanwei The Characterization of HBV ccc DNA in Placenta Tissues from Pregnant Women with Positive HBsAg 11192 Zhong Yanwei Recombinant Alfa-2b Interferon Plus Ribavirin Therapy in Children Aged 1 to 6 Years With CHC11212 Zhong Yanwei Gene Chip Detected Hepatitis B Virus &Quota&Quot Determinant Variants 20004 Zhong Yanwei The Correlation between HBV cccDNA and Clinical Features in Children with CHB20005 Zhong Yanwei The Predictive Value of HBV cccDNA for Antiviral Therapy in Children with CHB20006 Zhong Yanwei Is the Fetus with HBV Possible Infected Through the Route of Placenta?20007 Zhong Yanwei Relationship between IL28B Gene Polymorphism and Antiviral Efficacy in Children with CHC20119 Zhong Yanwei Baseline Factors Predicting Antiviral Efficacy in Children with HBeAg Positive Chronic Hepatitis B 20120 Zhong Yanwei HBsAg Decline is Associated with High Loss Rates of HBsAg in Children with HBeAg Positive CHB20123 Zhong Yanwei The Effect of Myeloid Derived Suppressor Cells in Children with Chronic Hepatitis B Infection11344 Zhou Bin HBV rtA181T and rtM204I Mutants Originate Independently during NAs Antiviral Therapy10691 Zhou Dongkai The Clinical Significance of HINT2 Expression in Hepatocellular Carcinoma10502 Zhou Jiajia NANOG Modulates Chemoresistance of Liver Cancer Stem Cells by Activating Stat3/ABCB1 Pathway11131 Zhou Jialing Diagnosis Model of HBV Related Compensated Cirrhosis by Ultrasonography and Transient Elastography11108 Zhou Jingjing Two Cases of Bile Duct Injury after TACE20049 Zhou Ji-Yuan PDGF-BB as A Biomarker for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B10631 Zhou Lingyun Biological Characteristics and Impacts of Truncated HBsAg Mutant Expressed by HBV rtA181T Mutation20091 Zhou Xinmin Vitamin D Supplementation Therapy for Primary Biliary Cirrhosis: A Retrospective Clinical Study10260 Zhu Chuanlong EFTUD2 Restricts Hepatitis B Virus Gene Expression and Replication Through RIG-I Mediated Pathway11351 Zhu Feng-cai Immunogenicity and Efficacy of A 10&mug Recombinant Yeast-Derived Hepatitis B Vaccine in Newborns20068 Zhu Xiang Study of the Inhibitory Effect of TMEM2 in HBV Infection into Hepatocytes20077 Zhu Xiang Transmembrane Protein 2 Inhibits Hepatitis B Virus Infection in L02 Cells

accepted abstracts apasl2016-alphabetical order 20160113 1/18apasl.info/apasl2016/doc/abstract...

Documents